Registration Form • Nov 14, 2024
Registration Form
Open in ViewerOpens in native device viewer
2024/2025
Albion VCTs Prospectus Top Up Offers
Albion Enterprise VCT PLC
Albion Technology & General VCT PLC
Albion Crown VCT PLC
12 November 2024

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION
IF YOU ARE IN ANY DOUBT ABOUT THE CONTENTS OF THIS DOCUMENT OR AS TO WHAT ACTION YOU SHOULD TAKE, YOU ARE RECOMMENDED TO SEEK YOUR OWN FINANCIAL ADVICE IMMEDIATELY FROM YOUR STOCKBROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL ADVISER AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000 (THE "FSMA").
THIS DOCUMENT CONSTITUTES A REGISTRATION DOCUMENT (THE "REGISTRATION DOCUMENT") ISSUED BY ALBION ENTERPRISE VCT PLC, ALBION TECHNOLOGY & GENERAL VCT PLC AND ALBION CROWN VCT PLC (THE "COMPANIES"). ADDITIONAL INFORMATION RELATING TO THE COMPANIES IS CONTAINED IN A SECURITIES NOTE ISSUED BY THE COMPANIES (THE "SECURITIES NOTE"). THIS REGISTRATION DOCUMENT, THE SECURITIES NOTE AND A SUMMARY (THE "SUMMARY") HAVE BEEN PREPARED IN ACCORDANCE WITH THE PROSPECTUS REGULATIONS RULES MADE UNDER FSMA (THE "PROSPECTUS REGULATIONS RULES") AND HAVE BEEN APPROVED BY THE FINANCIAL CONDUCT AUTHORITY (THE "FCA") AS COMPETENT AUTHORITY UNDER THE UK VERSION OF REGULATION (EU) 2017/1129 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (THE "UK PROSPECTUS REGULATION") AND CONSTITUTE A PROSPECTUS ISSUED BY THE COMPANIES DATED 12 NOVEMBER 2024. THE FCA ONLY APPROVES THIS REGISTRATION DOCUMENT AS MEETING THE STANDARDS OF COMPLETENESS, COMPREHENSIBILITY AND CONSISTENCY IMPOSED BY THE UK PROSPECTUS REGULATION, AND SUCH APPROVAL SHOULD NOT BE CONSIDERED AS AN ENDORSEMENT OF THE ISSUERS THAT ARE THE SUBJECT OF THIS REGISTRATION DOCUMENT. THIS REGISTRATION DOCUMENT HAS BEEN DRAWN UP AS PART OF A SIMPLIFIED PROSPECTUS IN ACCORDANCE WITH ARTICLE 14 OF THE UK PROSPECTUS REGULATION. YOU ARE ADVISED TO READ THE PROSPECTUS IN FULL.
THIS DOCUMENT HAS BEEN PREPARED FOR THE PURPOSES OF COMPLYING WITH THE PROSPECTUS REGULATION RULES, ENGLISH LAW AND THE RULES OF THE FCA AND THE INFORMATION DISCLOSED MAY NOT BE THE SAME AS THAT WHICH WOULD BE DISCLOSED IF THIS DOCUMENT HAD BEEN PREPARED IN ACCORDANCE WITH THE LAWS OF A JURISDICTION OUTSIDE ENGLAND.
Each Company, the Directors of each of the Companies and the Proposed Directors of each of the Companies (whose names are set out on page 83) accept responsibility for the information contained in the Registration Document. To the best of the knowledge of each Company, its Directors and Proposed Directors, the information contained in the Registration Document is in accordance with the facts and the Registration Document makes no omission likely to affect its import.
(Incorporated in England and Wales with Registered number 05990732)
(Incorporated in England and Wales with Registered number 04114310)
(Incorporated in England and Wales with Registered number 03495287)
Copies of this Registration Document, the Securities Note and the Summary (and any supplementary prospectus published by the relevant Company or Companies) are available free of charge from the offices of the Companies' investment manager, Albion Capital Group LLP, 1 Benjamin Street, London EC1M 5QL and on the "VCT HUB" page of Albion Capital's website: www.albion.capital/offers.
The Companies' Shares have not been, nor will they be, registered in the United States under the United States Securities Act of 1933, as amended, (Securities Act) or under the securities laws of Canada, Australia, Japan or South Africa (each a Restricted Territory) and they may not be offered or sold directly or indirectly within the United States or any of the Restricted Territories or to, or for the account or benefit of, US Persons (as defined in Regulation S made under the Securities Act) or any national, citizen or resident of the United States or any of the Restricted Territories. No offer of the Companies' Shares has been, nor will be, made, directly or indirectly, in or into the United States or any of the Restricted Territories or in any other jurisdiction where to do so would be unlawful. The distribution of this document in jurisdictions other than the UK may be restricted by law and therefore persons into whose possession this document comes should inform themselves about and observe any of those restrictions. Any failure to comply with any of those restrictions may constitute a violation of the securities law of any such jurisdiction. Any person (including, without limitation, custodians, nominees and trustees) who may have a contractual or legal obligation to forward this document should read the paragraph entitled "Overseas Investors" on pages 77 and 78 of this Registration Document before taking any action.
Defined terms can be located on pages 79 to 82.
YOUR ATTENTION IS DRAWN TO THE RISK FACTORS ON PAGES 4 TO 6. AN INVESTMENT IN THE COMPANIES IS ONLY SUITABLE FOR INVESTORS WHO ARE CAPABLE OF EVALUATING THE RISKS AND MERITS OF SUCH AN INVESTMENT AND HAVE SUFFICIENT RESOURCES TO BEAR ANY LOSS THAT MAY ARISE.
| 04 | Risk Factors |
|---|---|
| 07 | Part I: The Directors and the Manager |
| 21 | Part II: Investment Policies of the Companies |
| 23 | Part III: Section A: Financial Information |
| 33 | Section B: Pro forma financial information |
| 41 | Part IV: Portfolio Information |
| 46 | Part V: General Information |
| 46 | Section A: Albion Enterprise VCT - General Information |
| 54 | Section B: Albion Technology & General VCT - General Information |
| 61 | Section C: Albion Crown VCT - General Information |
| 69 | Section D: General Information on the Companies |
| 79 | Part VI: Definitions |
| 83 | Directors, Manager and Advisers |
The following are those risk factors which are material to each Company and of which each Company's respective Directors are aware. Material risk factors relating to the Shares are contained in the Securities Note. Additional factors which are not presently known to the Directors, or that the Directors currently deem immaterial, may also have an effect on their respective Company's business, financial condition or results of operations.
The Directors of each Company are responsible for the determination of the Company's investment objective and policy and have overall responsibility for the Company's activities including the review of investment activity and performance.
The Directors, in conjunction with the Manager, are determined to maintain the VCT status of their respective Company and in this regard recognise its critical importance to existing and potential Shareholders. Each Board has put in place procedures designed to ensure that VCT status is maintained and monitor this closely through the provision of regular reports from the Manager and the VCT tax status adviser on the status of the relevant Company against the various tests that it must meet to maintain its VCT status.
Each Board is also responsible for monitoring and managing the controllable risks to profits and assets in its respective Company. They have each established an ongoing formal process to ensure that risk exposure is reviewed regularly. As part of this regular review, each Board assesses its service providers with the Manager in order to discuss their performances against expectations as well as to improve both service standards and value for money.
The Directors, all of whom are non-executive and independent of the Manager with the exception of Patrick Reeve, the Chairman of Albion Capital, who sits on the boards of Albion Enterprise VCT and Albion Technology & General VCT, together have relevant experience of similar investment funds, regulatory organisations, corporate governance of listed companies, the private equity industry and investee companies. There is no conflict of interest between the duties carried out by a Director on behalf of their Company and their private interests, save in respect of Patrick Reeve, who is a director of Albion Enterprise VCT and Albion Technology & General VCT and a member and Chairman of the Manager and is, therefore, interested in those contracts with the Companies referred to in paragraphs 4 in each of Sections A and B in Part V below. It is proposed that Patrick Reeve will resign from the boards of Albion Enterprise VCT and Albion Technology & General VCT on completion of the AAEV/AADV Merger and AATG/ KAY Merger.
The Listing Rules require listed companies, such as each Company, to include in their annual report and accounts a statement of how they apply the principles of good corporate governance set out in the UK Corporate Governance Code and whether or not they have complied with the best practice provisions set out in the UK Corporate Governance Code throughout their accounting period. Where any of the provisions have not been complied with, the relevant Company must state the provisions in question, the period within which non-compliance occurred and the reasons for non-compliance.
Each Company is a member of the Association of Investment Companies and as such the AIC Code, which complements the UK Corporate Governance Code and provides a framework of best practice for investment companies, including VCTs, applies to it. The Financial Reporting Council has confirmed that, by following the AIC Corporate Governance Guide for Investment Companies (which was produced in conjunction with the AIC Code in February 2019) (the "AIC Guide"), VCT boards should fully meet their obligations in relation to the UK Corporate Governance Code and UKLR 6.6.6R(6) in the Listing Rules.
The AIC Code provides that, to give greater transparency to investors, it should be best practice for members to state in their annual report whether they are adhering to the principles and following the recommendations contained in the AIC Code and if not, to explain why and, where appropriate, to detail the steps they intend to take to bring themselves into compliance in the future. AIC member companies may also make a statement that, by reporting against the AIC Code and by following the AIC Guide, they are meeting their obligations under the UK Corporate Governance Code (and associated disclosure requirements under UKLR 6.6.6R(6)) and as such do not need to report further on issues contained in the UK Corporate Governance Code which are irrelevant to them (as explained in the AIC Guide).
Christopher Burrows has 35 years' experience in international leadership consulting, executive search and assessment. Having graduated in Anthropology from the University of Cambridge, he started his consulting career with Whitehead Mann and subsequently became the youngest partner at Goddard Kay Rogers. He retired from Russell Reynolds Associates in 2018, having been a managing director for the last 13 years of his executive career there. His principal focus was advising clients and investors on board appointments and organisation strategy across biotechnology, medtech, diagnostics, healthcare services, pharmaceuticals and digital technologies.
Rhodri Whitlock is a chartered accountant and has over 25 years' experience as a partner at Pannells LLP, BDO LLP, PKF Littlejohn LLP and Crowe U.K. LLP providing a range of assurance services and advice to listed and private companies. During that time he worked closely with the non-executive boards of a significant number of investment and infrastructure funds and also has considerable experience of high growth businesses and sectors including MedTech, FinTech, software as a service, healthcare and e-commerce. More recently he worked with the independent regulator, the Financial Reporting Council and now runs his own consultancy business, HPL Associates Limited and AQRA Limited. He is also a member of the ICAEW's Audit and Assurance Faculty Board.
Philippa Latham started her career in corporate finance in the City and has experience in industry as a corporate analyst. She was a non-executive director from 2005 to 2015 at James Latham PLC, an AIM listed company, where she served as the chair of the Audit Committee for seven years. She currently holds four non-executive director roles, one of which is Lucy Group Ltd where she is chair of the Audit Committee.
Patrick Reeve was formerly the managing partner of Albion Capital and became chairman in 2019. He is a director of Albion Development VCT, Albion Technology & General VCT and Albion Enterprise VCT. He is on Albion Capital's Valuation Committee and its Risk Management Committee. He joined Close Brothers Group plc in 1989 before establishing Albion Capital (originally Close Ventures Ltd) in 1996. Prior to Close he qualified as a chartered accountant before joining Cazenove & Co. He has an MA in Modern Languages from Oxford University and a BA in Sanskrit from SOAS. Although considered non-independent for governance purposes, he contributes both direct investment experience and a wider perspective in the venture capital markets.
Patrick Reeve will be stepping down from the Boards of Albion Enterprise VCT, Albion Development VCT and Albion Technology & General VCT on the date of the implementation of their respective Merger or 31 December 2024 (whichever is the earlier).
Assuming the merger of Albion Enterprise VCT and Albion Development VCT proceeds, Ben Larkin and Lord O'Shaughnessy will join the board of Albion Enterprise VCT.
Ben Larkin was appointed director of Albion Development VCT on 5 December 2016 and became chairman of Albion Development VCT on 8 July 2019. Assuming the merger of Albion Enterprise VCT and Albion Development VCT proceeds, he will become chairman of Albion Enterprise VCT.
He is a partner at an international law firm, Jones Day. He heads up the business reorganisation practice across Europe. He has spent the majority of his career advising public and private boards on aspects of corporate governance and has particular expertise in the infrastructure and real estate sectors. Recent mandates include Airwave (the mobile communication network for the UK's emergency services) and National Car Parks. Prior to joining Jones Day, he led the business recovery and reconstruction division of Berwin Leighton Paisner LLP for 14 years.
Lord O'Shaughnessy was appointed director of Albion Development VCT on 8 July 2019. Assuming the merger of Albion Enterprise VCT and Albion Development VCT proceeds, he will become a director of Albion Enterprise VCT.
Lord O'Shaughnessy has operated at the highest levels across UK Government, including as a Parliamentary Under Secretary in the Department for Health & Social Care with key policy responsibilities including life sciences; medicines pricing and regulation; preparing the health and social care sectors for Brexit; and, data, digital and technology, including cyber security. He was created a life peer in 2015 taking the title Baron O'Shaughnessy, of Maidenhead in the Royal County of Berkshire, and previously served as Director of Policy in No.10 Downing Street. He is a senior partner at Newmarket Strategy, a healthcare and life sciences consultancy and a Trustee at Health Data Research UK.
The Directors and the Proposed Directors of Albion Enterprise VCT are currently or have been within the last five years, a member of the administrative, management or supervisory bodies or partners of the companies and partnerships mentioned below:
| Christopher Burrows | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Enterprise VCT |
| Rhodri Whitlock | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Enterprise VCT | Crowe U.K. LLP |
| AQRA Limited | Lightspeed Solar Partners PLC (dissolved)* |
| HPL Associates Limited | |
| Pannells LLP |
* Dissolved following a compulsory strike off from the Register of Companies at Companies House
| Philippa Latham | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Enterprise VCT | |
| Lucy Group Ltd | |
| Maldon Salt Limited | |
| Maldon Holdings Limited | |
| Trebartha Estates Limited |
| Patrick Reeve | ||||
|---|---|---|---|---|
| Past directorships/partnerships (five years) | ||||
| ACP I Shareco Limited | ||||
| ACP Ordinary Shareco Limited | ||||
| Albion Community Power Limited | ||||
| The Association of Investment Companies | ||||
| Ywastefood Limited (dissolved)* | ||||
* Voluntarily struck off the Register of Companies at Companies House
| Ben Larkin | ||
|---|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) | |
| Albion Development VCT | ||
| Jones Day |
| Lord O'Shaughnessy | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Development VCT | Floreat Education (dissolved)* |
| Health Data Research UK | Floreat Education Academies Trust (dissolved)* |
| Newmarket Strategy Holdings Limited | Human.ai Limited (dissolved)* |
| Newmarket Strategy Limited | Mayforth Consulting Limited (dissolved)* |
* Voluntarily struck off the Register of Companies at Companies House
The Board of Albion Enterprise VCT consists solely of non-executive directors of whom Christopher Burrows is Chairman and Rhodri Whitlock is the Senior Independent Director. All of the Albion Enterprise VCT Directors and the Proposed Directors, other than Patrick Reeve who is the Chairman of the Manager, are considered by the Board of Albion Enterprise VCT to be independent of the Manager and the Board does not consider that a Director's tenure reduces his/her ability to act independently.
By reporting against the AIC Code and by following the AIC Guide, as at the date of this document Albion Enterprise VCT complies with its obligations under the UK Corporate Governance Code.
In accordance with the AIC Code, all Directors submit themselves for re-election annually.
The Board of Albion Enterprise VCT has delegated certain responsibilities and functions to the audit and risk committee, the remuneration committee and the nomination committee.
The audit and risk committee, chaired by Rhodri Whitlock, operates within clearly defined terms of reference and comprises all the Albion Enterprise VCT Directors, other than Patrick Reeve. The duties of the audit and risk committee include reviewing the annual and interim accounts, the system of internal controls, the terms of appointment of the auditors together with their remuneration, and ensuring that auditor objectivity and independence is safeguarded in the provision of non-audit services by the auditors. It also provides a forum through which the auditors may report to the Board of Albion Enterprise VCT and meets at least twice yearly.
The remuneration committee, chaired by Philippa Latham, comprises all the Albion Enterprise VCT Directors, other than Patrick Reeve, and reviews the Directors' responsibilities and salaries against the market as required.
The nomination committee, chaired by Christopher Burrows, comprises all the Albion Enterprise VCT Directors, other than Patrick Reeve, and is convened for the purpose of considering the appointment of additional directors as and when considered appropriate. In considering appointments to the Board of Albion Enterprise VCT, the nomination committee takes into account the ongoing requirements of Albion Enterprise VCT and the need to have a balance of skills, knowledge, experience and diversity within its Board.
Clive Richardson has extensive experience across a range of private and public international healthcare and technology focused firms from start-ups to mid-cap companies. He was Head of Equities Research for Investec Bank, and worked as a strategy consultant for L.E.K. Consulting, a leading global strategy firm. He has held non-executive director roles and served as an executive board member on CIS Healthcare Limited and Clinisys Group Limited, both decision support healthcare software companies. In his most recent role, he served as COO and CEO for Akari Therapeutics, PLC, a NASDAQ listed biotechnology company.
Margaret Payn has extensive experience across the financial sector. She qualified as a chartered accountant at KPMG in London and has worked for a number of financial institutions in the UK, Australia and Asia, including nine years at Schroders where she held CFO and COO roles and seven years in similar roles at Westpac and ANZ Banking Group. Her most recent executive role was at AMP Capital where she held the positions of CFO/COO within the asset management division and was responsible for leading the finance, product, strategy and support functions. She retired from this position in 2018. She is a non-executive director of Bendigo and Adelaide Bank, a company listed on the Australian Stock Exchange and was until recently a non-executive director of JPMorgan Mid Cap Investment Trust plc.
Assuming the merger between Albion Technology & General VCT and Albion KAY VCT proceeds, Margaret Payn will resign from the board of Albion Technology & General VCT on completion of the merger.
David Benda qualified as a chartered accountant with Coopers & Lybrand in London in 1994 and whilst working for them, he took up secondment in both the New York and Prague offices until his departure in 1997. Since then, he has worked in various corporate broking roles, including for HSBC James Capel and Winterflood Securities where he focused on investment companies. He is currently a Managing Director at Deutsche Numis where he heads up the corporate side of the listed fund team and co-heads the team overall. He has extensive experience on advising UK listed closed-ended funds and managing corporate transactions which includes fundraisings, reorganisations and restructurings. He is a member of the Association of Investment Companies Broking Committee and the LSE Investment Funds Group.
Peter Moorhouse has extensive corporate finance experience of advising boards and management teams in the UK, Europe and US, particularly on equity financing and mergers and acquisitions, with specialisations in the healthcare and technology sectors. He also has valuable experience of private equity investment, including early-stage financing, strategic development, IPOs and exits. His most recent role was as a Managing Director and Senior Advisor in Morgan Stanley's investment banking business, principally advising companies in the healthcare, pharmaceutical and biotech sectors. Prior to this, he was a Managing Director at Merrill Lynch, having started his corporate finance career at Smith New Court.
Assuming the merger between Albion Technology & General VCT and Albion KAY VCT proceeds, Peter Moorhouse will resign from the board of Albion Technology & General VCT on completion of the merger.
See Albion Enterprise VCT
Assuming the merger of Albion Technology & General VCT and Albion KAY VCT proceeds, Fiona Wollocombe, Swarupa Pathakji and Simon Thorpe will join the board of Albion Technology & General VCT.
Fiona Wollocombe was appointed Chairman of Albion KAY VCT on 1 May 2019 and became chairman of Albion KAY VCT on 10 June 2021. Assuming the merger between Albion Technology & General VCT and Albion KAY VCT proceeds, she will become a director of Albion Technology & General VCT. Fiona Wollocombe will not be seeking re-election at the 2025 AGM of the Enlarged VCT.
Fiona Wollocombe has been a non-executive director for a number of companies in the VCT sector including being chairman of Artemis VCT plc and a director of Maven Income and Growth VCT PLC. She is chairman of Amati AIM VCT plc and also chairs the Trustees of the Scottish Ballet Endowment Fund. Her previous career was in equity capital markets at NatWest Markets/Deutsche Bank.
Swarupa Pathakji was appointed a director of Albion KAY on 1 November 2021. Assuming the merger between Albion Technology & General VCT and Albion KAY VCT proceeds, she will become a director of Albion Technology & General VCT.
Swarupa Pathakji has extensive experience across the financial sector, with an in-depth understanding of investment in growth companies and experience in exits and valuations. She qualified as a chartered accountant at Deloitte before spending time in mergers and acquisitions at Merrill Lynch. She moved to Duke Street, a mid-market Private Equity firm, in 2007 and has served as a non-executive director on the boards of a number of companies across multiple sectors. She is currently non-executive director of OFS (DS) Holdings Ltd, where she is chair of the audit committee, and of Motorpoint Group PLC.
Simon Thorpe was appointed a director of Albion KAY VCT on 1 September 2023. Assuming the merger between Albion Technology & General VCT and Albion KAY VCT proceeds, he will become a director of Albion Technology & General VCT.
Simon Thorpe is a qualified Chartered Accountant and former chairman and director of Cambridge Angels with extensive experience of analysing and investing in early-stage public and private companies in the technology and technology enabled healthcare sectors. His previous roles include Chief Operating Officer for European Equity Research and UBS Global Equity Research.
The Directors and Proposed Directors of Albion Technology & General VCT are currently or have been within the last five years, a member of the administrative, management or supervisory bodies or partners of the companies and partnerships mentioned below:
| Clive Richardson | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Technology & General VCT | Akari Therapeutics, PLC |
| Cintoa Limited | Bravo Inns Limited |
| Con-join-ai Ltd | Bravo Inns II Limited |
| 5 Hertford Street Limited | |
| Top Coast Investment Limited |
| Current directorships/partnerships | Past directorships/partnerships (five years) |
|---|---|
| Albion Technology & General VCT | Jenna Payn Limited (dissolved)* |
| Bendigo and Adelaide Bank Limited | JPMorgan Mid Cap Investment Trust plc** |
| Blue Araucaria Pty Ltd | 65 Holland Park Limited |
| DFKP Pty Ltd | |
| Patricia Payn Superannuation Pty Ltd | |
| Sandhurst Trustees Limited |
* Voluntarily struck off the Register of Companies at Companies House
** in members' voluntary (solvent) liquidation
| David Benda | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Technology & General VCT | Roman Landing Leaseholds Limited |
| Peter Moorhouse | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Technology & General VCT | Cranston Scott Consultants Limited* |
| Alchemy Wines Limited | |
| Framlingham College Enterprises Limited |
* Voluntarily struck off the Register of Companies at Companies House
| Patrick Reeve | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| See Albion Enterprise VCT |
| Fiona Wollocombe | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion KAY VCT | Artemis VCT plc (dissolved)* |
| Amati AIM VCT plc |
* Dissolved following a members' voluntary (solvent) liquidation
| Swarupa Pathakji | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion KAY VCT | SCS Group Limited |
| Motorpoint Group PLC | |
| OFS (DS) Holdings Limited |
| Simon Thorpe | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion KAY VCT | Cambridge Angels Ltd |
| Delta2020 LLP | Cambridge Angels Group Ltd |
| Inngot Limited | Eagle Genomics Limited |
| Rockspring Nominees Limited | |
| Ubio Limited | |
| University of Manchester Innovation Factory Limited |
The Board of Albion Technology & General VCT consists solely of non-executive directors. Clive Richardson is Chairman and Margaret Payn is Senior Independent Director. All of the Directors, other than Patrick Reeve who is the Chairman of the Manager, and the Proposed Directors, are considered by the Board of Albion Technology & General VCT to be independent of the Manager and the Board does not consider that a Director's tenure reduces his/her ability to act independently.
By reporting against the AIC Code and by following the AIC Guide, as at the date of this document Albion Technology & General VCT complies with its obligations under the UK Corporate Governance Code.
In accordance with the AIC Code, all Directors submit themselves for re-election annually.
The Board of Albion Technology & General VCT has delegated certain responsibilities and functions to the audit and risk committee, the remuneration committee, the nomination committee and the management engagement committee.
The audit and risk committee, chaired by Margaret Payn, operates within clearly defined terms of reference and comprises all the Albion Technology & General VCT Directors, other than Patrick Reeve. The duties of the audit and risk committee include reviewing the annual and interim accounts, the system of internal controls, the terms of appointment of the auditors together with their remuneration, and ensuring that auditor objectivity and independence is safeguarded in the provision of non-audit services by the auditors. It also provides a forum through which the auditors may report to the Board of Albion Technology & General VCT and meets at least twice yearly. Assuming the merger of Albion Technology & General VCT and Albion KAY VCT proceeds, Simon Thorpe will succeed Margaret Payn as chairman of the audit and risk committee.
The remuneration committee, chaired by Peter Moorhouse, comprises all the Albion Technology & General VCT Directors, other than Patrick Reeve, and reviews the Directors' responsibilities and salaries against the market as required. David Benda will succeed Peter Moorhouse as Chairman of the Remuneration Committee on completion of the merger.
The nomination committee, chaired by Clive Richardson, comprises all the Albion Technology & General VCT Directors, other than Patrick Reeve, and is convened for the purpose of considering the appointment of additional directors as and when considered appropriate. In considering appointments to the Board of Albion Technology & General VCT, the nomination committee takes into account the ongoing requirements of Albion Technology & General VCT and the need to have a balance of skills, experience and knowledge within its Board, together with diversity of experience and approach.
The management engagement committee, chaired by Clive Richardson, comprises all the Albion Technology & General VCT Directors, other than Patrick Reeve, and has been formed to review arrangements with the Manager.
James Agnew has a background in investment banking and private equity fund management. From 1996 to 2005 he worked for Credit Suisse First Boston in New Zealand and London, where he was involved in a wide range of investment banking transactions including mergers and acquisitions and equity and debt fundraising, as well as general corporate finance advice. He is currently a partner at Harwood Private Equity LLP (formerly J O Hambro Capital Management), which he joined in 2005, where his responsibilities include origination, monitoring and execution of private equity investments.
Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, James Agnew will resign from the board on Albion Crown VCT on completion of the merger.
Pam Garside is an experienced healthcare investor, expert in digital health and an adviser to government, NHS and private sector organisations in the UK and US. She is a Fellow of the Judge Business School at the University of Cambridge and a member of the investment committee of Cambridge Enterprise, the technology transfer company of the University. She is chairman of Cambridge Angels, a board member of several other healthcare companies and co-chair of the Cambridge Health Network.
Ian Spence is highly experienced in the technology sector, having researched and advised companies in this industry over 25 years. He began his career as a journalist at the Investors Chronicle before moving into investment banking where, over the next 13 years working for Granville, Robert W Baird, Bridgewell and Altium, he developed a specialisation as a highly-regarded technology analyst. During this time, he was twice voted TechMARK Analyst of the Year. In 2007, he founded Megabuyte, which has grown to be one of the most respected and widely read sources of financial and corporate intelligence in the European technology sector. He is chairman of the company and has an extensive network across the European technology sector and beyond.
Tony Ellingham has a background in banking and extensive experience at board level. From 2015 to 2022 he worked for Starling Bank Limited and was Chief Financial Officer from July 2016, responsible for the financial management, treasury and reporting of the bank. Prior to Starling, he was at Lloyds Banking Group where he was Finance, Risk & Operations Director of Group Corporate Treasury and Divisional Risk Officer for Finance. He has also held Chief Financial Officer roles at EIIB, Gulf International Bank and Schroder Private Banking.
Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, Tony Ellingham will resign from the board on Albion Crown VCT on completion of the merger.
Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, Richard Glover, Ann Berresford and Richard Wilson will join the board of Albion Crown VCT and Richard Glover will become chairman of Albion Crown VCT.
Richard Glover was appointed a director of Albion Venture Capital Trust on 8 November 2017 and was appointed chairman of Albion Venture Capital Trust on 1 August 2018. Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, he will become chairman of Albion Crown VCT.
Richard Glover spent 15 years in industrial relations and HR management roles in the 1970s and 1980s first with ICI and then with Grand Metropolitan. Since 1990 he has been involved with two private equity backed businesses in the service sector: first, in 1990 the British School of Motoring (BSM), where, as MD and later CEO, he took the company through flotation and then sale to RAC; and in 2000, the accountancy training company ATC International, where he became the majority shareholder in 2003, running the business in Eastern Europe until it was sold in 2011. He has also held a number of non-executive director positions in the service sector and remains extensively involved with the Worshipful Company of Haberdashers and its education activities.
Ann Berresford was appointed a director of Albion Venture Capital Trust on 8 November 2017. Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, she will become a director of Albion Crown VCT.
Ann Berresford is a chartered accountant with a background in the financial services and energy sectors. She holds a degree in Organic Chemistry and trained as an accountant with Grant Thornton. After a period in audit, she moved into industry and spent over 20 years working in financial management and treasury roles, initially with Clyde Petroleum plc and then with the Bank of Ireland Group. Since 2006, she has had a number of non-executive roles, including positions at Bath Building Society, the Pensions Protection Fund, Triodos Renewables plc, Hyperion Insurance Group and the Pensions Regulator. She is currently a non-executive director of Secure Trust Bank plc.
Richard Wilson was appointed a director of Albion Venture Capital Trust on 1 May 2020. Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, he will become a director of Albion Crown VCT.
Richard Wilson is highly experienced in the asset management sector and was CEO of BMO Global Asset Management and previously CEO of F&C Asset Management plc, where he led the company's acquisition by BMO Financial Group and subsequent integration into BMO Global Asset Management. He began his asset management career in 1988 as a U.K. equity manager with HSBC Asset Management (formerly Midland Montagu). He then joined Deutsche Asset Management (formerly Morgan Grenfell), where he rose to managing director, global equities. From Deutsche, he moved to Gartmore Investment Management in 2003 as head of international equity investments before joining F&C in 2004. He is an independent non-executive director of Insight Investment Management.
The Directors and Proposed Directors of Albion Crown VCT are currently or have been within the last five years, a member of the administrative, management or supervisory bodies or partners of the companies and partnerships mentioned below:
| James Agnew | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Crown VCT | Assisi Pet Care Group Limited |
| APC Technology Group Limited | Assisi Pet Care Limited |
| Appleseed Bidco Limited | Assisi Pet Care Midco Limited |
| Appleseed Holdco Limited | Coventbridge (USA) Inc. |
| Certify Holdings Inc. | Harwood Capital LLP |
| Coventbridge Group Limited | Hollings Limited |
| Coventbridge Holding Corporation | Pet Munchies Limited |
| F.G. Curtis Limited | Scientific Health Limited |
| Harwood Private Equity LLP | Slim Holdings Limited (dissolved) |
| Medica Packaging Limited | Sourcebio International Limited |
| Medication Packaging Holdco Limited | Source Bioscience Limited |
| North Atlantic Value GP III Limited | The Slimming Clinic Limited (in administration) |
| North Atlantic Value GP 4 Limited | Town and Country Petfoods Limited |
| North Atlantic Value GP 5 LLP | |
| North Atlantic Value GP 6 LLP | |
| SMT Corp. | |
| Specialist Components Limited | |
| Utilities Infrastructure Provider Limited |
| Current directorships/partnerships | Past directorships/partnerships (five years) |
|---|---|
| Albion Crown VCT | Medefer Limited |
| Cambridge Angels Group Ltd | TheCareRooms Ltd |
| Cambridge Angels Ltd | Visante Limited (dissolved) |
| Cambridge Health Network Limited | Whizz-Kidz |
| Cicely Saunders International | |
| Newhealth Limited | |
| Nickleby Impress LLP | |
| Punchdrunk Enrichment Limited |
| Current directorships/partnerships | Past directorships/partnerships (five years) |
|---|---|
| Agnosco Capital Limited | IX Acquisition Corp. |
| Albion Crown VCT | |
| IS Research Ltd | |
| Quartix Technologies PLC |
| Tony Ellingham | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Crown VCT | Fleet Mortgages Limited |
| MFSI Holdings Limited | |
| Murmur Financial Services Internationalal DAC | |
| Starling Bank Limited | |
| Starling FS Services Limited | |
| Starling Group Holdings Limited |
| Richard Glover | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albanurseries Ltd | |
| Albion Venture Capital Trust | |
| Haberdashers' Monmouth Estates Limited | |
| Hatcham Charitable Trust |
| Ann Berresford | |
|---|---|
| Current directorships/partnerships | Past directorships/partnerships (five years) |
| Albion Venture Capital Trust | |
| Secure Trust Bank Public Limited Company |
| Current directorships/partnerships | Past directorships/partnerships (five years) |
|---|---|
| Albion Venture Capital Trust | |
| CC Lower Clapton LLP | |
| Insight Investment Funds Management Limited | |
| Insight Investment International Limited | |
| Insight Investment Management Limited | |
| Insight Investment Management (Global) Limited |
The Board of Albion Crown VCT consists solely of non-executive directors of whom James Agnew is Chairman and Pam Garside is Senior Independent Director. All of the Albion Crown VCT Directors and the Proposed Directors are considered by the Board of Albion Crown VCT to be independent of the Manager. The Board does not consider that a Director's tenure reduces his/her ability to act independently.
By reporting against the AIC Code and by following the AIC Guide, as at the date of this document, Albion Crown VCT complies with its obligations under the UK Corporate Governance Code.
In accordance with the AIC Code, all Directors submit themselves for re-election annually.
The Board of Albion Crown VCT has delegated certain responsibilities and functions to the audit and risk committee, the remuneration committee and the nomination committee.
The audit and risk committee, chaired by Tony Ellingham, operates within clearly defined terms of reference and comprises all the Albion Crown VCT Directors. The duties of the audit and risk committee include reviewing the annual and interim accounts, the system of internal controls, the terms of appointment of the auditors together with their remuneration, and ensuring that auditor objectivity and independence is safeguarded in the provision of non-audit services by the auditors. It also provides a forum through which the auditors may report to the Board of Albion Crown VCT and meets at least twice yearly. Assuming the merger of Albion Crown VCT and Albion Venture Capital Trust proceeds, Ann Berresford will succeed Tony Ellingham as chairman of the audit and risk committee.
The remuneration committee, chaired by Ian Spence, operates within clearly defined terms of reference and comprises all the Albion Crown VCT Directors. It reviews the Directors' responsibilities and salaries against the market as required.
The nomination committee, chaired by James Agnew, operates within clearly defined terms of reference and comprises all the Albion Crown VCT Directors. The committee is convened for the purpose of considering the appointment of additional directors as and when considered appropriate. In considering appointments to the Board of Albion Crown VCT, the nomination committee takes into account the ongoing requirements of Albion Crown VCT and the need to have a balance of skill, experience and knowledge within its Board, together with diversity of experience and approach.
Albion Capital Group LLP is the Companies' investment manager and is a limited liability partnership incorporated on 6 November 2008 and registered in England and Wales under number OC341524 pursuant to the Limited Liability Partnerships Act 2000 and LEI number 213800132YFSOIX6N117. The registered office and principal place of business of Albion Capital is 1 Benjamin Street, London EC1M 5QL (telephone number 020 7601 1850). Albion Capital is authorised and regulated by the Financial Conduct Authority as an Authorised UK AIFM as required under the EU AIFM Directive that came into force in July 2013. The principal legislation under which Albion Capital operates is the Limited Liability Partnership Act 2000 and the applicable provisions of CA 2006 (and regulations made thereunder). Albion Capital is domiciled in England and its website can be found at www.albion.capital. Information on this website does not form part of the Prospectus unless that information is incorporated by reference into the Prospectus. Albion Capital currently manages some £1 billion, which it is managing under delegation.
The following are specifically responsible for the management and administration of the Companies.
Will Fraser-Allen, BA (Hons), FCA, has been managing partner of Albion Capital since 2019 and chairs the investment committee. He is on the board of the AIC and sits on the Venture Capital Committee of the BVCA. He joined Albion Capital in 2001 and became deputy managing partner in 2009. He qualified as a chartered accountant and has a BA in History from Southampton University.
Patrick Reeve MA, FCA, See Albion Enterprise VCT above.
Dr. Andrew Elder, MA, FRCS, practised as a neurosurgeon before starting his career in investment. He is head of the healthcare investment team and became deputy managing partner of Albion Capital in 2019. He joined Albion Capital in 2005 and became a partner in 2009. He has an MA plus Bachelors of Medicine and Surgery from Cambridge University. He is a Fellow of the Royal College of Surgeons (England).
Vikash Hansrani, BA (Hons), FCA, is a partner and oversees the finance and administration of all funds under Albion Capital's management. He is on Albion Capital's valuation committee and its risk management committee. He qualified as a chartered accountant with RSM, before joining Albion Capital in 2010. He has a BA in Accountancy & Finance from Nottingham Business School.
Valerie Aelbrecht, MSc, MSc, is an investment manager. She joined Albion Capital in 2022. She was at Cherry Ventures after being a founder and operator for 8 years in the foodtech space. She holds an MSc in Applied Economics from the University of Antwerp and an MSc in International Business Management & Entrepreneurship from Kingston University.
Dr. Leigh Brody, PhD, joined Albion Capital as Investment Manager in 2021 and focuses on transformative technologies and therapeutics opportunities emerging from UCL. She has over a decade of experience as a startup founder, gained her PhD in Biochemistry from Imperial College London, and also holds a BSc in Biochemistry from Simmons University.
Adam Chirkowski, MA (Hons), is a partner focusing on B2B and ClimateTech investments. Prior to joining Albion Capital in 2013, he spent five years working in corporate finance at Rothschild. He has a first class degree in Industrial Economics and a Masters in Corporate Strategy and Governance from Nottingham University.
Emil Gigov, BA (Hons), FCA, is a partner focusing on B2B SaaS businesses. He joined Albion Capital in 2000 and became a partner in 2009. He graduated from the European Business School, London, with a BA Degree in European Business Administration.
Dr. Molly Gilmartin, BM BCh, BA, is an investment director. She joined Albion Capital in 2022 from McKinsey & Company. Before that, she was Chief Commercial Officer of Induction Healthcare Group which completed an IPO on AIM in 2019. Before this, she was a founding team member of start-up Pando and an NHS Clinical Entrepreneur as a medical doctor.
David Grimm, MSc, is a partner focusing on DeepTech investments. He joined Albion Capital in 2016 as investment manager and was made partner in 2023. He has spent 10 years investing in early-stage technology-differentiated opportunities, including 4 years at Spark Ventures prior to joining Albion Capital. He holds an MSc in Natural Sciences.
Ed Lascelles, BA (Hons), heads up the technology investment team. He joined Albion Capital from ING Barings in 2004, having started his career advising public companies, and became a partner in 2009. He holds a first class honours degree in Philosophy from UCL.
Paul Lehair MSc, MA, is a partner who joined Albion Capital in 2019 having spent five years at Citymapper. He also worked at Viagogo and in M&A at Citigroup. He has a dual Masters degree in European Political Economy from the LSE and Political Science and Sciences Po Paris.
Catriona McDonald, BA (Hons), is a partner specialising in technology investing. She joined Albion Capital in 2018 from Goldman Sachs where she worked on IPOs, M&A and leveraged buyouts in New York and London. She graduated from Harvard University, majoring in Economics.
Kibriya Rahman, MMath, is an investment manager. He joined Albion Capital in 2022. He was previously at Funding Circle and Formula 1. Before this, he worked at OC&C Strategy Consultants. He graduated from Oxford University with an MMath degree.
Jane Reddin, BA (Hons), heads up the platform team. She joined Albion Capital in 2020 and became a partner in 2022. Prior to joining Albion Capital, she spent six years as Talent Adviser at Balderton Capital and then co-founded The Talent Stack. She graduated from Durham University with a BA in French and German.
Dr. Christoph Ruedig, MBA, is a partner focusing on digital health. He originally practised radiology and was responsible for M&A in healthcare at GE and venture capital with 3i. He joined Albion Capital in 2011 and became a partner in 2014. He holds a degree in medicine from Ludwig-Maximilians University and an MBA from INSEAD.
Nadine Torbey, MSc, BEng, is a partner who joined Albion Capital in 2018 from Berytech Fund Management. She holds a BSc in Electrical and Computer Engineering from the American University of Beirut and an MSc in Innovation Management and Entrepreneurship from Brown University.
Robert Whitby-Smith, BA (Hons), FCA, is a partner focusing on software investing. His background was in corporate finance at KPMG, Credit Suisse First Boston and ING Barings, after qualifying as a chartered accountant. He joined Albion Capital in 2005 and became a partner in 2009. He graduated from Reading University with a BA in History.
Jay Wilson, MBA, MMath, is a partner focusing on FinTech. He joined Albion Capital in 2019 from Bain & Company, where he had been a consultant since 2016, and became a partner in 2023. Prior to this he graduated from London Business School with an MBA having spent eight years as a broker at ICAP Securities.
Marco Yu, PhD, MRICS, heads up the renewables team and became partner in 2023. Prior to joining Albion Capital in 2007, he qualified as a Chartered Surveyor with Bouygues, and advised on large capital projects with EC Harris. He has a first class degree in economics from Cambridge University and a PhD in construction economics from UCL.
The Company will invest in a broad portfolio of higher growth businesses across a variety of sectors of the UK economy including higher risk technology companies. Allocation of assets will be determined by the investment opportunities which become available but efforts will be made to ensure that the portfolio is diversified both in terms of sector and stage of maturity of company.
Funds held prior to investing in VCT qualifying assets or for liquidity purposes will be held as cash on deposit, invested in floating rate notes or similar instruments with banks or other financial institutions with high credit ratings or invested in liquid open-ended equity funds providing income and capital equity exposure (where it is considered economic to do so). Investment in such open-ended equity funds will not exceed 10 per cent. of the Company's assets at the time of investment.
The Company shall be able to (i) continue to hold VCT assets that were previously acquired in accordance with the Company's investment policy that applied at the time of investment and (ii) acquire such VCT assets through a merger with another VCT where such assets were previously acquired by that target VCT (in accordance with its investment policy that applied at the time of investment).
Risk is spread by investing in a number of different businesses within venture capital trust qualifying industry sectors using a mixture of securities. The maximum amount which the Company will invest in a single company is 15 per cent. of the Company's assets at cost, thus ensuring a spread of investment risk. The value of an individual investment may increase over time as a result of trading progress and it is possible that it may grow in value to a point where it represents a significantly higher proportion of total assets prior to a realisation opportunity being available.
The Company's maximum exposure in relation to gearing is restricted to 10 per cent. of its adjusted share capital and reserves.
The Company will invest in a broad portfolio of unquoted growth and technology businesses. Allocation of assets will be determined by the investment opportunities which become available but efforts will be made to ensure that the portfolio is diversified in terms of sectors and stages of maturity of portfolio companies.
Funds held prior to investing in VCT qualifying assets or for liquidity purposes will be held as cash on deposit, invested in floating rate notes or similar instruments with banks or other financial institutions with high credit ratings or invested in liquid open-ended equity funds providing income and capital equity exposure (where it is considered economic to do so). Investment in such open-ended equity funds will not exceed 7.5 per cent. of the Company's assets at the time of investment.
The Company shall be able to (i) continue to hold VCT assets that were previously acquired in accordance with the Company's investment policy that applied at the time of investment and (ii) acquire such VCT assets through a merger with another VCT where such assets were previously acquired by that target VCT (in accordance with its investment policy that applied at the time of investment).
Risk is spread by investing in a number of different businesses within VCT qualifying industry sectors using a mixture of securities. The maximum the Company will invest in a single company is 15 per cent. of the Company's assets at cost at the time of investment. The value of an individual investment is expected to increase over time as a result of trading progress and a continuous assessment is made of investments' suitability for sale. It is possible that individual holdings may grow in value to a point where they represent a significantly higher proportion of total assets prior to a realisation opportunity being available.
The Company's maximum exposure in relation to gearing is restricted to 10 per cent. of the adjusted share capital and reserves. The Directors do not have any intention of utilising long-term gearing.
The Company invests in a broad portfolio of smaller, unquoted growth businesses across a variety of sectors including higher risk technology companies. Investments take the form of equity or a mixture of equity and loans.
Whilst allocation of funds is determined by the investment opportunities which are available, efforts are made to ensure that the portfolio is diversified both in terms of sector and stage of maturity of investee businesses. Funds held pending investment or for liquidity purposes will be held principally as cash on deposit.
The Company shall be able to (i) continue to hold VCT assets that were previously acquired in accordance with the Company's investment policy that applied at the time of investment and (ii) acquire such VCT assets through a merger with another VCT where such assets were previously acquired by that target VCT (in accordance with its investment policy that applied at the time of investment).
Risk is spread by investing in a number of different businesses within venture capital trust qualifying industry sectors using a mixture of securities, as permitted. The maximum amount which the Company will invest in a single portfolio company is 15 per cent. of the Company's assets at cost, thus ensuring a spread of investment risk. The value of an individual investment may increase over time as a result of trading progress and it is possible that it may grow in value to a point where it represents a significantly higher proportion of total assets prior to a realisation opportunity being available.
The Company's maximum exposure in relation to gearing is restricted to the amount of its adjusted share capital and reserves. The Directors do not have any intention of utilising long-term gearing.
In addition to the investment policies described above, investment allocation and risk diversification for each Company are substantially governed by the relevant HMRC tests which must be satisfied in order for a Company to maintain its status under Venture Capital Trust legislation. Those tests are summarised in paragraph 5 of Section D of Part V of this document.
No Company will make a material change to its published investment policy without obtaining the prior approval of its Shareholders.
Albion Enterprise VCT has produced audited annual statutory accounts for the year ended 31 March 2024 (which contains the information as set out below). Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the statutory accounts for the financial year ended 31 March 2024 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 31 March 2024 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report contains a description of Albion Enterprise VCT's financial condition, changes in financial condition and results of operations for that financial year, and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.
Where this document makes reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | March 2024 Annual Report |
|---|---|
| Income statement | Page 73 |
| Balance sheet | Page 74 |
| Statement of changes in equity | Page 75 |
| Statement of cash flows | Page 76 |
| Accounting policies and notes | Pages 77-91 |
| Auditor's report | Pages 65-71 |
Albion Enterprise VCT's published annual report and accounts for the year ended 31 March 2024 contains, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for each of those periods:
| Description | March 2024 Annual Report |
|---|---|
| Objective | Page 7 |
| Investment policy | Page 7 |
| Performance summary | Pages 8-9 |
| Results and dividend | Page 10 |
| Chairman's statement | Pages 10-13 |
| Strategic report | Pages 14-26 |
| Portfolio summary | Pages 27-28 |
| Valuation policy | Pages 77-78 |
The key figures that summarise Albion Enterprise VCT's financial position in respect of the financial year ended 31 March 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | March 2024 Annual Report |
|---|---|
| Gains on investments (£'000) | 4,883 |
| Investment income (£'000) | 1,697 |
| Profit on ordinary activities before taxation (£'000) | 3,334 |
| Earnings per share (p) | 3.30 |
| Dividends per share (p) | 6.28 |
| Total assets (£'000) | 142,003 |
| Net assets (£'000) | 140,648 |
| NAV per share (p) | 125.77 |
The net asset value per Albion Enterprise VCT Share as at 30 June 2024 (being the most recent unaudited NAV per Share published by Albion Enterprise VCT prior to the publication of this document) was 136.10p per Albion Enterprise VCT Share.
Save for the payment of £17.5 million in respect of buybacks and the payment of dividends (net of the amount reinvested pursuant to the dividend reinvestment scheme), there has been no significant change in the financial position of Albion Enterprise VCT since 31 March 2024 (being the last date up to which Albion Enterprise VCT has published audited financial information).
Albion Development VCT has produced audited annual statutory accounts for the financial year ended 31 December 2023 and a half-yearly financial report for the six-month period ended 30 June 2024 (which contain the information as set out below). Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the annual statutory accounts for the year ended 31 December 2023 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 31 December 2023 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report and the half-yearly financial report each contains a description of Albion Development VCT's financial condition, changes in financial condition and results of operations for the relevant period , and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.
Where these documents make reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts and the half yearly financial reports referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Income statement | Page 70 | Page 16 |
| Balance sheet | Page 71 | Page 17 |
| Statement of changes in equity | Page 72 | Page 18 |
| Statement of cash flows | Page 73 | Page 19 |
| Accounting policies and notes | Pages 74-88 | Pages 20-26 |
| Auditor's report | Pages 63-68 | N/A |
Albion Development VCT's published annual report and accounts for the financial year ended 31 December 2023 and the half-yearly report for the six-month period ended 30 June 2024 contain, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for each of those periods:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Investment policy | Page 7 | Page 6 |
| Performance summary | Pages 8-9 | Page 7 |
| Results and dividend | Page 10 | Page 8 |
| Chairman's statement/interim management report | Pages 10-13 | Pages 8-11 |
| Strategic report | Pages 14-26 | N/A |
| Portfolio summary | Pages 27-28 | Pages 12-14 |
| Valuation policy | Pages 74-75 | Pages 20-21 |
The key figures that summarise Albion Development VCT's financial position in respect of the financial year ended 31 December 2023 and for the unaudited six month period ended 30 June 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Gains on investments (£'000) | 7,294 | 14,124 |
| Investment income (£'000) | 1,508 | 1,115 |
| Profit on ordinary activities before taxation (£'000) | 5,753 | 13,576 |
| Earnings per share (p) | 4.29 | 9.50 |
| Dividends per share (p) | 4.51 | 2.22 |
| Total assets (£'000) | 120,409 | 143,820 |
| Net assets (£'000) | 119,633 | 142,762 |
| NAV per share (p) | 88.70 | 95.91 |
The net asset value per Albion Development VCT Share as at 30 June 2024 (being the most recent unaudited NAV per Share published by Albion Development VCT prior to the publication of this document) was 95.91p per Albion Development VCT Share.
Save for the payment of £8.2 million in respect of buybacks and the payment of dividends (net of the amount reinvested pursuant to the dividend reinvestment scheme), there has been no significant change in the financial position of Albion Development VCT since 30 June 2024 (being the last date up to which Albion Development VCT has published interim unaudited financial information).
Albion Technology & General VCT has produced audited annual statutory accounts for the financial year ended 31 December 2023 and a half-yearly financial report for the six-month period ended 30 June 2024 (which contain the information as set out below). Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the statutory accounts for the financial year ended 31 December 2023 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 31 December 2023 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report and the half-yearly financial report each contains a description of Albion Technology & General VCT's financial condition, changes in financial condition and results of operations for the relevant period, and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.Where this document makes reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Income statement | Page 73 | Page 16 |
| Balance sheet | Page 74 | Page 17 |
| Statement of changes in equity | Page 75 | Page 18 |
| Statement of cash flows | Page 76 | Page 19 |
| Accounting policies and notes | Pages 77-92 | Pages 20-26 |
| Auditor's report | Pages 65-71 | N/A |
Albion Technology & General VCT's published annual report and accounts for the financial year ended 31 December 2023 and the half-yearly report for the six-month period ended 30 June 2024 contain, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for each of those periods:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Objective | Page 7 | Page 6 |
| Investment policy | Page 7 | Page 6 |
| Performance summary | Page 8-9 | Page 7 |
| Results and dividend | Page 10 | Page 8 |
| Chairman's statement/ interim management statement | Pages 10-13 | Pages 8-11 |
| Strategic report | Pages 14-27 | N/A |
| Portfolio summary | Pages 28-29 | Pages 12-13 |
| Valuation policy | Pages 77-78 | Pages 20-21 |
The key figures that summarise Albion Technology & General VCT's financial position in respect of the financial year ended 31 December 2023 and for the unaudited six month period ended 30 June 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Gains on investments (£'ooo) | 5,992 | 9,851 |
| Investment income (£'000) | 1,687 | 1,249 |
| Profit on ordinary activities before taxation (£'000) | 4,347 | 9,228 |
| Earnings per share (p) | 2.49 | 4.99 |
| Dividends per share (p) | 3.72 | 1.80 |
| Total assets (£'000) | 128,415 | 150,593 |
| Net assets (£'000) | 127,322 | 143,830 |
| NAV per share (p) | 71.99 | 75.09 |
The net asset value per Albion Technology & General VCT Share as at 30 June 2024 (being the most recent unaudited NAV per Share published by Albion Technology & General VCT prior to the publication of this document) was 75.09p per Albion Technology & General VCT Share.
There has been no significant change in the financial position of Albion Technology & General VCT since 30 June 2024 (being the last date up to which Albion Technology & General VCT has published interim unaudited financial information).
Albion KAY VCT has produced audited annual statutory accounts for the year ended 31 December 2023 as well as a half-yearly financial report for the six-month period ended 30 June 2024 (which contain the information as set out below). Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the statutory accounts for the financial year ended 31 December 2023 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 31 December 2023 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report and the half-yearly financial report each contains a description of Albion KAY VCT's financial condition, changes in financial condition and results of operations for the relevant period, and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.
Where these documents make reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts and half yearly financial reports referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Income statement | Page 73 | Page 16 |
| Balance sheet | Page 74 | Page 17 |
| Statement of changes in equity | Page 75 | Page 18 |
| Statement of cash flows | Page 76 | Page 19 |
| Accounting policies and notes | Pages 77-91 | Pages 20-26 |
| Auditor's report | Pages 65-71 | N/A |
Albion KAY VCT's published annual report and accounts for the year ended 31 December 2023 and the half-yearly financial report for the six-month period ended 30 June 2024 contain, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for each of those periods:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Objective | Page 7 | Page 6 |
| Investment policy | Page 7 | Page 6 |
| Performance summary | Pages 8-9 | Page 7 |
| Results and dividend | Page 10 | Page 9 |
| Chairman's statement/interim management statement | Pages 10-13 | Pages 8-11 |
| Strategic Report | Pages 14-26 | N/A |
| Portfolio summary | Pages 27-28 | Pages 12-13 |
| Valuation policy | Page 77-78 | Pages 20-21 |
The key figures that summarise Albion KAY VCT's financial position in respect of the financial year ended 31 December 2023 and the unaudited six-month period ended on 30 June 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | December 2023 Annual Report |
Unaudited Half-Year Report for six months ended 30 June 2024 |
|---|---|---|
| Gains on investments (£'000) | 3,306 | 10,961 |
| Investment income (£'000) | 1,498 | 940 |
| Profit/(loss) on ordinary activities before taxation (£'000) | 2,136 | 10,544 |
| Earnings/(loss) per share (p) | 0.42 | 1.94 |
| Dividends per share (p) | 1.05 | 0.51 |
| Total assets (£'000) | 106,185 | 135,248 |
| Net assets (£'000) | 105,490 | 122,641 |
| NAV per share (p) | 20.37 | 21.78 |
The net asset value per Albion KAY VCT Share as at 30 June 2024 (being the most recent unaudited NAV per Share published by Albion KAY VCT prior to the publication of this document) was 21.78p per Albion KAY VCT Share.
Save for the payment of £9.0 million in respect of buybacks and the payment of dividends (net of the amount reinvested pursuant to the dividend reinvestment scheme), there has been no significant change in the financial position of Albion KAY VCT since 30 June 2024 (being the last date up to which Albion KAY VCT has published interim unaudited financial information).
Albion Crown VCT has produced audited annual statutory accounts for the financial year ended 30 June 2024 (which contain the information as set out below).
Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the statutory accounts for the financial year ended 30 June 2024 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 30 June 2024 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report contains a description of Albion Crown VCT's financial condition, changes in financial condition and results of operations for that financial year and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.
Where this document makes reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | June 2024 Annual Report |
|---|---|
| Income statement | Page 73 |
| Balance sheet | Page 74 |
| Statement of changes in equity | Page 75 |
| Statement of cash flows | Page 76 |
| Accounting policies and notes | Pages 77-91 |
| Auditor's report | Pages 65-71 |
Albion Crown VCT's published annual report and accounts for the financial year ended 30 June 2024 contains, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for that period:
| Description | June 2024 Annual Report |
|---|---|
| Investment policy | Page 7 |
| Performance summary | Pages 8-9 |
| Results and dividend | Page 10 |
| Chairman's Statement | Pages 10-13 |
| Strategic Report | Pages 14-26 |
| Portfolio summary | Pages 27-29 |
| Valuation policy | Pages 77-78 |
The key figures that summarise Albion Crown VCT's financial position in respect of the financial year ended 30 June 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | June 2024 Annual Report |
|---|---|
| Gains on investments (£'000) | 2,817 |
| Investment income (£'000) | 1,458 |
| Profit/(loss) on ordinary activities before taxation (£'000) | 2,165 |
| Earnings/(loss) per share (p) | 0.75 |
| Dividends per share (p) | 1.61 |
| Total assets (£'000) | 99,828 |
| Net assets (£'000) | 97,044 |
| NAV per share (p) | 32.20 |
The net asset value per Albion Crown VCT Share as at 30 June 2024 (being the most recent audited NAV per Share published by Crown Place VCT prior to the publication of this document) was 32.20p per Crown Place VCT Share.
There has been no significant change in the financial position of Albion Crown VCT since 30 June 2024 (being the last date up to which Albion Crown VCT has published audited financial accounts).
Albion Venture Capital Trust has produced audited annual statutory accounts for the year ended 31 March 2024 (which contains the information as set out below). Johnston Carmichael LLP of 7-11 Melville Street, Edinburgh EH3 7PE reported on the statutory accounts for the financial year ended 31 March 2024 without qualification and without statements under sections 495 to 497 of CA 2006.
The annual report for the year ended 31 March 2024 was prepared in accordance with Financial Reporting Standard 102 and applicable United Kingdom law and the relevant Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts'. The annual report contains a description of Albion Venture Capital Trust's financial condition, changes in financial condition and results of operations for that financial year, and the pages referred to in the following tables are being incorporated by reference and can be accessed at the following website: www.albion.capital.
Where this document makes reference to other documents, such other documents are not incorporated into and do not form part of this Prospectus. Those parts of the annual statutory accounts referred to above which are not being incorporated into this document by reference are either not relevant for investors or are covered elsewhere in this Prospectus.
| Description | March 2024 Annual Report |
|---|---|
| Income statement | Page 71 |
| Balance sheet | Page 72 |
| Statement of changes in equity | Page 73 |
| Statement of cash flows | Page 74 |
| Accounting policies and notes | Pages 75-88 |
| Auditor's report | Pages 63-69 |
Albion Venture Capital Trust's published annual report and accounts for the year ended 31 March 2024 contains, on the pages specified in the table below, descriptions of its financial condition (in both capital and revenue terms), details of its investment activity and portfolio exposure and changes in its financial condition for each of those periods:
| Description | March 2024 Annual Report |
|---|---|
| Objective | Page 7 |
| Investment policy | Page 7 |
| Performance summary | Page 8-9 |
| Results and dividend | Page 10 |
| Chairman's statement | Pages 10-13 |
| Strategic report | Pages 14-26 |
| Portfolio summary | Pages 27-28 |
| Valuation policy | Pages 75-76 |
The key figures that summarise Albion Venture Capital Trust's financial position in respect of the financial year ended 31 March 2024 which have been extracted without material adjustment from the historical financial information referred to above, are set out in the following table:
| Description | March 2024 Annual Report |
|---|---|
| Net losses on investments (£'000) | (4,800) |
| Investment income (£'000) | 1,556 |
| Loss on ordinary activities before taxation (£'000) | (4,923) |
| Loss per share (p) | (3.53) |
| Dividends per share (p) | 2.46 |
| Total assets (£'000) | 62,668 |
| Net assets (£'000) | 62,009 |
| NAV per share (p) | 44.93 |
The net asset value per Albion Venture Capital Trust Share as at 30 June 2024 (being the most recent unaudited NAV per Share published by Albion Venture Capital Trust prior to the publication of this document) was 44.90p per Albion Venture Capital Trust Share.
There has been no significant change in the financial position of Albion Venture Capital Trust since 31 March 2024 (being the last date up to which Albion Venture Capital Trust has published audited financial information).
Johnston Carmichael LLP is regulated by the Institute of Chartered Accountants of Scotland.
The following table sets out the average annual total (unaudited) NAV return of the Companies for the ten years to 30 June 2024, the five years to 30 June 2024, the three years to 30 June 2024 and the year to 30 June 2024, comprising dividends paid and change in net asset value:
| 10 years (p.a.) | 5 years (p.a.) | 3 years (p.a.) | 1 year | |
|---|---|---|---|---|
| Albion Enterprise VCT | 9.8% | 8.1% | 7.0% | 11.7% |
| Albion Technology & General VCT | 5.2% | 4.2% | 3.6% | 3.6% |
| Albion Crown VCT | 7.2% | 5.1% | 3.7% | 2.1% |
Source: Albion Capital.
The following table sets out the annual return (unaudited and comprising change in net asset value and dividends paid per share) for each of the Companies for each of the 5 years to 30 June 2024:
| Year to 30 June 2020 |
Year to 30 June 2021 |
Year to 30 June 2022 |
Year to 30 June 2023 |
Year to 30 June 2024 |
|
|---|---|---|---|---|---|
| Albion Enterprise VCT | -1.7% | 20.8% | 6.5% | 2.9% | 11.7% |
| Albion Technology & General VCT | -3.9% | 16.7% | 5.7% | 1.4% | 3.6% |
| Albion Crown VCT | -0.4% | 15.9% | 6.1% | 3.1% | 2.1% |
Performance for the year to 30 June 2020 was affected by a cautious approach to valuations due to the Covid-19 pandemic
Source: Albion Capital.
The following is the full text of the report from MHA (a trading name of MacIntyre Hudson LLP) to the Directors, the Proposed Directors and Howard Kennedy Corporate Services LLP
The Directors and Proposed Directors
Albion Enterprise VCT PLC, Albion Technology & General VCT PLC and Albion Crown VCT PLC
1 Benjamin Street
London EC1M 5QL
and
Howard Kennedy Corporate Services LLP No. 1 London Bridge London SE1 9BG
12 November 2024
Dear Sirs
Albion Enterprise VCT PLC (AAEV), Albion Technology & General VCT PLC (AATG) and Albion Crown VCT PLC (CRWN) (together the Companies and each a Company)
We report on the pro forma financial information (the Pro Forma Financial Information) set out in Section B of Part III of the registration document dated 12 November 2024 (the Registration Document) of the Companies (which together with the securities note and the summary of the Companies comprises the prospectus of the Companies (the Prospectus)), which has been prepared on the basis described in the notes to the Pro Forma Financial Information, for illustrative purposes only, to provide information about how the Mergers (as defined in the Registration Document), taking into account the Offers, might have affected the financial information presented on the basis of the accounting policies adopted by each Company in preparing the financial statements for the year ended 31 March 2024 in respect of AAEV (in respect of the Pro Forma Statement of Net Assets and the Pro Forma Statement of Earnings), in respect of AATG as at 30 June 2024 (in respect of the Pro Forma Statement of Net Assets) and the year ended 31 December 2023 (in respect of the Pro Forma Statement of Earnings), and for the year ended 30 June 2024 in respect of CRWN (in respect of the Pro Forma Statement of Net Assets and the Pro Forma Statement of Earnings). This report is required by item 11.5 of Annex 3 of the UK version of EU Commission Delegated Regulation (2019/980) as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (the UK Prospectus Delegated Regulation or PD Regulation) and is given for the purpose of complying with that item and for no other purpose.
Save for any responsibility arising under item 11.5 of Annex 3 of the PD Regulation to any person as and to the extent there provided, to the fullest extent permitted by law we do not assume any responsibility and will not accept any liability to any other person for any loss suffered by any such person as a result of, arising out of, or in connection with, this report or our statement, given solely for the purposes of complying with item 11.5 of Annex 3 of the PD Regulation, or consenting to its inclusion in the Registration Document.
It is the responsibility of the directors and the proposed directors of the Companies (the Directors) to prepare the Pro Forma Financial Information in accordance with item 11.5 of Annex 3 of the PD Regulation.
It is our responsibility to form an opinion, as required by section 3 of Annex 20 of the PD Regulation, as to the proper compilation of the Pro Forma Financial Information and to report that opinion to you.
Save for any responsibility arising under the PD Regulation to any person as and to the extent there provided, to the fullest extent permitted by law we do not assume any responsibility and will not accept any liability to any other person for any loss suffered by any such other person as a result of, arising out of, or in connection with, this report or our statement, which are included, in the form and context in which they are included, with our consent, and with our having authorised the contents of this Section B of Part III, as required by, and given solely for the purposes of complying with, item 11.5 of Annex 3 of the PD Regulation.
In providing this opinion we are not updating or refreshing any reports or opinions previously made by us on any financial information used in the compilation of the Pro Forma Financial Information, nor do we accept responsibility for such reports or opinions beyond that owed to those to whom those reports or opinions were addressed by us at the dates of their issue.
We conducted our work in accordance with the Standards of Investment Reporting issued by the Financial Reporting Council in the United Kingdom. The work that we performed for the purpose of making this report, which involved no independent examination of any of the underlying financial information, consisted primarily of comparing the unadjusted financial information with the source documents, considering the evidence supporting the adjustments and discussing the Pro Forma Financial Information with the Directors.
We planned and performed our work so as to obtain the information and explanations we considered necessary in order to provide us with reasonable assurance that the Pro Forma Financial Information has been properly compiled on the basis stated and that such basis is consistent with the accounting policies of the Companies.
Our work had not been carried out in accordance with auditing or other standards and practices generally accepted in any jurisdictions other than the United Kingdom and accordingly should not be relied upon as if it had been carried out in accordance with those other standards and practices.
In our opinion:
This report has been produced, and included in the Registration Document, at the request of the Companies. We hereby confirm that we have authorised the contents of, and consent to, the inclusion of this report in the Registration Document for the purpose of the Prospectus. This consent is included in the Registration Document in accordance with item 1.3 of the PD Regulation.
For the purposes of Prospectus Regulation Rule 5.3.2R(2)(f) we are responsible for this report as part of the Registration Document and declare that, to the best of our knowledge, the information contained in this report is in accordance with the facts and that the report makes no omission likely to affect its import. This declaration is included in the Registration Document in compliance with item 1.2 of Annex 3 of the PD Regulation.
Yours faithfully
MHA
(a trading name of MacIntyre Hudson LLP)
On 24 July 2024, the Boards announced that they had entered into discussions regarding the possibility of merging the six Companies into three to achieve, amongst other things, cost savings, administration efficiency and simplicity, and would, subject to agreement in principle to implement the Mergers by all six Boards, put proposals to their respective Shareholders so as to be able to implement the Mergers. Agreement in principle has now been reached.
If the Mergers proceed, AADV would be merged into AAEV, KAY would be merged into AATG and AAVC would be merged into CRWN (AAEV, AATG and CRWN being the Acquirer VCTs and AADV, KAY and AAVC being the Target VCTs). The number of new Shares to be issued in an Acquirer VCT (Consideration Shares) will be calculated by reference to the respective net asset values of that Acquirer VCT and its relevant Target VCT. In the case of the CRWN/AAVC Scheme, it is proposed that AAVC Shareholders will be issued a new class of shares in CRWN (New CRWN Shares), which will account for the existing AAVC portfolio, and that the new share class will convert into CRWN Shares by reference to the respective net asset values of CRWN Share class and the New CRWN Share class as at 30 June 2026 (which will be based on the relative net asset value of the AAVC portfolio (as then contained in the New CRWN Share portfolio) - and the net asset value of the CRWN Share portfolio). The purpose of the different approach in the case of the CRWN/AAVC Scheme is to allow time for the existing AAVC portfolio, which was largely built up following the decision to change the VCT's investment policy in 2018, to mature. The detailed terms of the Schemes are set out in Part II of the Securities Note.
The below pro forma financial information has been prepared for the purposes of and in respect of the proposed Mergers.
The following pro forma financial information on AAEV has been prepared to illustrate the effect of the AAEV/AADV Merger and the AAEV Offer on AAEV's (i) audited net assets as at 31 March 2024 on the basis that the AAEV/AADV Merger and the acquisition by AAEV of the investment portfolio and all of the other assets and liabilities of AADV had been completed and the AAEV Offer had been fully subscribed on 31 March 2024 and (ii) income statement for the year ended 31 March 2024 on the basis that the AAEV/ AADV Merger and the acquisition by AAEV of the investment portfolio and all of the other assets and liabilities of AADV had been completed, and the AAEV Offer had been fully subscribed, on 1 April 2023. This pro forma financial information has been prepared in a manner consistent with the accounting policies of AAEV and AADV as adopted in their latest published accounts.
The pro forma financial information has been prepared for illustrative purposes only and, because of its nature, addresses a hypothetical situation and, therefore, does not represent AAEV's actual financial position or results nor is it indicative of the results that may or may not be achieved in the future.
| Adjustments | ||||||||
|---|---|---|---|---|---|---|---|---|
| AAEV (£'000) (Note 1) |
and liabilities of AADV (£'000) (Note 2) |
Acquisition of the assets | Expenses of the Merger (£'000) (Note 3) |
Other adjustments (£'000) (Note 4) |
Enlarged AAEV pro forma (£'000) (Note 5) |
|||
| Investments (at fair value) |
105,513 | 115,549 | 221,062 | |||||
| Debtors and prepayments |
176 | 92 | 268 | |||||
| Cash at bank and in hand |
36,314 | 28,179 | (907) | 19,400 | 82,986 | |||
| Creditors: amounts falling due within one year |
(1,355) | (1,058) | – | – | (2,413) | |||
| Net current assets | 35,135 | 27,213 | (907) | 19,400 | 80,841 | |||
| Net assets | 140,648 | 142,762 | (907) | 19,400 | 301,903 |
| Adjustments | |||||||
|---|---|---|---|---|---|---|---|
| AAEV (£'000) (Note 1) |
and liabilities of AADV (£'000) (Note 2) |
Acquisition of the assets | Expenses of the Merger (£'000) (Notes 3 and 4) |
Enlarged AAEV pro forma (£'000) (Notes 5 and 6) |
|||
| Net gains on investments | 4,883 | 7,294 | 12,177 | ||||
| Investment income | 1,697 | 1,508 | 3,205 | ||||
| Investment management fees | (2,563) | (2,660) | (5,223) | ||||
| Other expenses | (683) | (389) | (907) | (1,979) | |||
| Profit on ordinary activities before taxation |
3,334 | 5,753 | (907) | 8,180 | |||
| Tax on return on ordinary activities |
– | – | – | ||||
| Return on ordinary activities after tax |
3,334 | 5,753 | (907) | 8,180 |
The following pro forma financial information on AATG has been prepared to illustrate the effect of the AATG/KAY Merger and the AATG Offer on AATG's (i) unaudited net assets as at 30 June 2024 on the basis that the AATG/KAY Merger and the acquisition by AATG of the investment portfolio and all of the other assets and liabilities of KAY had been completed and the AATG Offer had been fully subscribed on 30 June 2024 and (ii) income statement for the year ended 31 December 2023 on the basis that the AATG/KAY Merger and the acquisition by AATG of the investment portfolio and all of the other assets and liabilities of KAY had been completed, and the AATG Offer had been fully subscribed, on 1 January 2023. This pro forma financial information has been prepared in a manner consistent with the accounting policies of AATG and KAY as adopted in their latest published accounts.
The pro forma financial information has been prepared for illustrative purposes only and, because of its nature, addresses a hypothetical situation and, therefore, does not represent AATG's actual financial position or results nor is it indicative of the results that may or may not be achieved in the future.
| AATG (£'000) (Note 1) |
Adjustments | |||||||
|---|---|---|---|---|---|---|---|---|
| Acquisition of the assets and liabilities of KAY (£'000) (Note 2) |
Expenses of Other the Merger adjustments (£'000) (£'000) (Note 3) (Note 4) |
Enlarged AATG pro forma (£'000) (Note 5) |
||||||
| Investments (at fair value) |
115,403 | 100,306 | 215,709 | |||||
| Debtors and prepayments |
141 | 71 | 212 | |||||
| Cash at bank and in hand |
35,049 | 34,871 | (867) | 29,100 | 98,153 | |||
| Creditors: amounts falling due within one year |
(6,505) | (12,607) | – | – | (19,112) | |||
| Net current assets | 28,685 | 22,335 | (867) | 29,100 | 79,253 | |||
| Provisions falling due after one year |
(258) | (258) | ||||||
| Net assets | 143,830 | 122,641 | (867) | 29,100 | 294,704 |
Expected Merger costs of approximately £867,000 (inclusive of VAT) are expected to be incurred and borne by AATG and KAY by their respective Merger net assets (ignoring Merger costs).
The gross proceeds (assuming full subscription and utilisation in full of the over-allotment facility) expected to be raised under the AATG Offer is £30 million. On the same basis, the AATG Offer costs payable by AATG are expected to be a maximum of £0.9 million. Adjustments have been made to reflect the AATG Offer on this basis.
The pro forma statement of net assets of AATG does not take account of any transactions of AATG or KAY, other changes in the value of the assets and liabilities or trading performance of AATG or KAY since 30 June 2024.
| Adjustments | |||||||
|---|---|---|---|---|---|---|---|
| AATG (£'000) (Note 1) |
and liabilities of KAY (£'000) (Note 2) |
Acquisition of the assets | Expenses of the Merger (£'000) (Notes 3 and 4) |
pro forma (£'000) (Notes 5 and 6) |
Enlarged AATG | ||
| Net gains on investments | 5,992 | 3,306 | 9,298 | ||||
| Investment income | 1,687 | 1,498 | 3,185 | ||||
| Investment management fees | (2,688) | (2,204) | (4,892) | ||||
| Other expenses | (644) | (464) | (867) | (1,975) | |||
| Profit on ordinary activities before taxation |
4,347 | 2,136 | (867) | 5,616 | |||
| Tax on return on ordinary activities |
– | – | – | ||||
| Return on ordinary activities after tax |
4,347 | 2,136 | (867) | 5,616 |
The financial information on AATG has been extracted without material adjustment from AATG's audited annual report for the year ended 31 December 2023 as incorporated into this document in Section A of Part III of this document.
The acquired assets and liabilities of AATG are the assets and liabilities of KAY as extracted without material adjustment from KAY's audited annual report for the year ended 31 December 2023 as incorporated into this document in Section A of Part III of this document. The continuing impact of the acquisition of the assets and liabilities of KAY is expected to be accretive to earnings (see further note 6 below).
Expected Merger costs of approximately £867,000 (inclusive of VAT) are expected to be incurred and borne by AATG and KAY by their respective Merger net assets (ignoring Merger costs). The Merger costs are one-off in nature and are not expected to have a continuing impact on AATG (see further note 6 below).
No account has been taken of the effects of any synergies, and of the costs or measures taken to achieve these synergies, that may have arisen had the Merger occurred on 1 January 2023 and that may subsequently have affected the results of AATG in the financial year ended 31 December 2023. The continuing impact of any synergies (once the costs or measures taken to achieve these synergies have been recovered) is expected to be accretive to earnings. The AATG Offer costs are not expected to have any impact on AATG's income statement as these will be charged against AATG's share premium account. No account has been taken of any income which might have been earned on the net proceeds of the AATG Offer.
The pro forma statement of earnings of AATG does not take account of any transactions of AATG or KAY, other changes in the value of the assets and liabilities or trading performance of AATG or KAY since 31 December 2023.
The short-term impact on AATG's earnings will be dilutive as the initial costs of the Merger will take time to recover though cost savings and any AATG Offer costs will initially be greater than interest earned on cash balances raised. Once the Merger costs have been recovered (a payback period of approximately 24 months expected) and the net funds raised have been successfully invested, the impact on AATG of the Merger and the AATG Offer is expected, in due course, to be accretive to earnings.
The following pro forma financial information on CRWN has been prepared to illustrate the effect of the CRWN/AAVC Merger and the CRWN Offer on CRWN's (i) audited net assets as at 30 June 2024 on the basis that the CRWN/AAVC Merger and the acquisition by CRWN of the investment portfolio and all of the other assets and liabilities of AAVC had been completed and the CRWN Offer had been fully subscribed on 30 June 2024 and (ii) income statement for the year ended 30 June 2024 on the basis that the CRWN/ AAVC Merger and the acquisition by CRWN of the investment portfolio and all of the other assets and liabilities of AAVC had been completed, and the CRWN Offer had been fully subscribed, on 1 July 2023. This pro forma financial information has been prepared in a manner consistent with the accounting policies of CRWN and AAVC as adopted in their latest published accounts.
The pro forma financial information has been prepared for illustrative purposes only and, because of its nature, addresses a hypothetical situation and, therefore, does not represent CRWN's actual financial position or results nor is it indicative of the results that may or may not be achieved in the future.
| Adjustments | ||||||||
|---|---|---|---|---|---|---|---|---|
| CRWN (£'000) (Note 1) |
Acquisition of the assets and liabilities of AAVC (£'000) (Note 2) |
Expenses of the Merger (£'000) (Note 3) |
Other adjustments (£'000) (Note 4) |
pro forma (£'000) (Note 5) |
Enlarged CRWN | |||
| Investments (at fair value) |
77,679 | 46,797 | 124,476 | |||||
| Debtors and prepayments |
60 | 69 | 129 | |||||
| Cash at bank and in hand |
22,089 | 15,802 | (580) | 29,100 | 66,411 | |||
| Creditors: amounts falling due within one year |
(2,784) | (659) | – | – | (3,443) | |||
| Net current assets | 19,365 | 15,212 | (580) | 29,100 | 63,097 | |||
| Net assets | 97,044 | 62,009 | (580) | 29,100 | 187,573 |
The financial information on CRWN has been extracted without material adjustment from CRWN's audited annual report for the year ended 30 June 2024 as incorporated into this document in Section A of Part III of this document.
The acquired assets and liabilities of CRWN are the assets and liabilities of AAVC as extracted without material adjustment from AAVC's audited annual report for the year ended 31 March 2024 as incorporated into this document in Section A of Part III of this document.
| CRWN (£'000) (Note 1) |
Adjustments | ||||||
|---|---|---|---|---|---|---|---|
| Acquisition of the assets and liabilities of AAVC (£'000) (Note 2) |
Expenses of the Merger (£'000) (Notes 3 and 4) |
Enlarged CRWN pro forma (£'000) (Notes 5 and 6) |
|||||
| Net gains/(losses) on investments |
2,817 | (4,800) | (1,983) | ||||
| Investment income | 1,458 | 1,556 | 3,014 | ||||
| Investment management fees | (1,598) | (1,206) | (2,804) | ||||
| Other expenses | (512) | (473) | (580) | (1,565) | |||
| Profit/(loss) on ordinary activities before taxation |
2,165 | (4,923) | (580) | (3,338) | |||
| Tax on return on ordinary activities |
– | – | – | ||||
| Return/(loss) on ordinary activities after tax |
2,165 | (4,923) | (580) | (3,338) |
Set out below are the largest investments of the combined Acquirer VCT and Target VCT as at the date of this document (the percentages of unaudited GAV being as at 30 June 2024) which have an aggregate value for each Company of at least 50 per cent. of its respective gross assets and/or where they have an individual value of greater than 5 per cent. of its respective gross assets. The tables show the approximate percentages each investment may represent in the Enlarged Acquirer VCT should the relevant Merger be completed. The following information is unaudited.
| AAEV | AADV | Enlarged Acquirer VCT |
|||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Quantexa Limited | 2,069 | 27,705 | 15.6% | 2,052 | 27,853 | 19.4% | 17.3% |
| Proveca Limited | 2,487 | 8,540 | 4.8% | 2,922 | 10,326 | 7.2% | 5.9% |
| Oviva AG | 2,601 | 5,633 | 3.2% | 2,601 | 5,633 | 3.9% | 3.5% |
| Radnor House School (TopCo) Limited |
1,729 | 3,528 | 2.0% | 1,560 | 3,183 | 2.2% | 2.1% |
| The Evewell Group Limited | 1,477 | 3,117 | 1.8% | 1,407 | 3,030 | 2.1% | 1.9% |
| Gravitee TopCo Limited (t/a Gravitee.io) |
2,168 | 3,499 | 2.0% | 1,490 | 2,383 | 1.7% | 1.8% |
| Panaseer Limited | 1,836 | 2,369 | 1.3% | 2,524 | 3,258 | 2.3% | 1.7% |
| Healios Limited | 3,013 | 3,108 | 1.7% | 2,401 | 2,456 | 1.7% | 1.7% |
| Runa Network Limited | 1,871 | 2,285 | 1.3% | 1,710 | 2,073 | 1.4% | 1.4% |
| The Street by Street Solar Programme Limited |
891 | 1,484 | 0.8% | 1,291 | 2,147 | 1.5% | 1.1% |
| Regenerco Renewable Energy Limited |
1,261 | 1,842 | 1.0% | 1,204 | 1,760 | 1.2% | 1.1% |
| Convertr Media Limited | 992 | 1,591 | 0.9% | 992 | 1,591 | 1.1% | 1.0% |
| Cantab Research Limited (T/A Speechmatics) |
1,359 | 1,539 | 0.9% | 1,337 | 1,515 | 1.1% | 0.9% |
| Peppy Health Limited | 1,372 | 1,372 | 0.8% | 1,424 | 1,424 | 1.0% | 0.9% |
| Treefera Limited | 1,371 | 1,371 | 0.8% | 1,272 | 1,272 | 0.9% | 0.8% |
| Aridhia Informatics Limited | 1,244 | 1,370 | 0.8% | 1,129 | 1,244 | 0.9% | 0.8% |
| Threadneedle Software Holdings Limited (T/A Solidatus) |
1,360 | 1,360 | 0.8% | 1,209 | 1,209 | 0.8% | 0.8% |
| Elliptic Enterprises Limited | 1,373 | 1,382 | 0.8% | 1,108 | 1,115 | 0.8% | 0.8% |
| Imandra Inc. | 815 | 965 | 0.5% | 1,114 | 1,291 | 0.9% | 0.7% |
| GX Molecular Inc (CS Genetics) | 1,143 | 1,149 | 0.6% | 1,079 | 1,084 | 0.8% | 0.7% |
| TransFICC Limited | 938 | 1,128 | 0.6% | 891 | 1,056 | 0.7% | 0.7% |
| OpenDialog AI | 1,139 | 1,139 | 0.6% | 1,028 | 1,028 | 0.7% | 0.7% |
| NuvoAir Holdings Inc. | 1,271 | 1,264 | 0.7% | 878 | 873 | 0.6% | 0.7% |
| Tem Energy Limited | 631 | 1,050 | 0.6% | 630 | 1,047 | 0.7% | 0.7% |
| Chonais River Hydro Limited | – | – | – | 1,705 | 2,082 | 1.4% | 0.6% |
| InCrowd Sports Limited | 721 | 967 | 0.5% | 786 | 1,055 | 0.7% | 0.6% |
| AAEV | Enlarged Acquirer VCT |
||||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Accelex Technology Limited | 782 | 1,153 | 0.6% | 546 | 805 | 0.6% | 0.6% |
| Alto Prodotto Wind Limited | 634 | 1,054 | 0.6% | 533 | 888 | 0.6% | 0.6% |
| Locum's Nest Limited | 602 | 919 | 0.5% | 663 | 1,010 | 0.7% | 0.6% |
| Papaya Technologies Limited | 944 | 944 | 0.5% | 864 | 864 | 0.6% | 0.6% |
| Instinct Digital Ltd | 943 | 943 | 0.5% | 796 | 796 | 0.6% | 0.5% |
| Beddlestead Limited | 966 | 736 | 0.4% | 1,026 | 783 | 0.5% | 0.5% |
| Toqio FinTech Holdings Limited | 1,279 | 699 | 0.4% | 1,369 | 748 | 0.5% | 0.4% |
| Trumpet Software Limited | 755 | 755 | 0.4% | 691 | 691 | 0.5% | 0.4% |
| Diffblue Limited | 745 | 745 | 0.4% | 682 | 682 | 0.5% | 0.4% |
| Seldon Technologies Limited | 1,046 | 651 | 0.4% | 1,002 | 623 | 0.4% | 0.4% |
| AATG | KAY | Enlarged Acquirer VCT |
|||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Quantexa Limited | 2,678 | 31,148 | 20.7% | 1,329 | 19,092 | 14.1% | 17.6% |
| Proveca Limited | 2,007 | 6,574 | 4.4% | 3,559 | 13,014 | 9.6% | 6.9% |
| Oviva AG | 2,694 | 5,834 | 3.9% | 1,489 | 3,219 | 2.4% | 3.2% |
| Gravitee TopCo Limited (t/a Gravitee.io) |
1,556 | 2,474 | 1.6% | 2,278 | 3,697 | 2.7% | 2.2% |
| Chonais River Hydro Limited | 2,169 | 3,172 | 2.1% | 2,428 | 2,964 | 2.2% | 2.1% |
| Radnor House School (TopCo) Limited |
2,710 | 5,529 | 3.7% | – | – | – | 1.9% |
| The Evewell Group Limited | 1,547 | 3,345 | 2.2% | 1,057 | 2,157 | 1.6% | 1.9% |
| Runa Network Limited | 2,748 | 3,476 | 2.3% | 1,575 | 1,854 | 1.4% | 1.9% |
| Panaseer Limited | 2,524 | 3,258 | 2.2% | 1,147 | 1,481 | 1.1% | 1.7% |
| Cantab Research Limited (T/A Speechmatics) |
2,901 | 3,287 | 2.2% | 898 | 1,017 | 0.8% | 1.5% |
| Healios Limited | 1,825 | 1,862 | 1.2% | 1,932 | 1,977 | 1.5% | 1.3% |
| Elliptic Enterprises Limited | 2,429 | 2,444 | 1.6% | 845 | 850 | 0.6% | 1.2% |
| The Street by Street Solar Programme Limited |
895 | 1,395 | 0.9% | 1,040 | 1,731 | 1.3% | 1.1% |
| TransFICC Limited | 1,275 | 1,605 | 1.1% | 1,305 | 1,411 | 1.0% | 1.1% |
| Gharagain River Hydro Limited | 1,526 | 2,093 | 1.4% | 620 | 772 | 0.6% | 1.0% |
| Peppy Health Limited | 1,481 | 1,481 | 1.0% | 1,359 | 1,359 | 1.0% | 1.0% |
| Regenerco Renewable Energy Limited |
822 | 1,170 | 0.8% | 988 | 1,444 | 1.1% | 0.9% |
| AATG | KAY | Enlarged Acquirer VCT |
|||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Treefera Limited | 1,475 | 1,475 | 1.0% | 1,097 | 1,097 | 0.8% | 0.9% |
| Convertr Media Limited | 1,105 | 1,772 | 1.2% | 482 | 773 | 0.6% | 0.9% |
| GX Molecular Inc (T/A CS Genetics) | 1,231 | 1,237 | 0.8% | 1,267 | 1,273 | 0.9% | 0.9% |
| NuvoAir Holdings Limited | 868 | 863 | 0.6% | 1,495 | 1,486 | 1.1% | 0.8% |
| Tem Energy Limited | 715 | 1,189 | 0.8% | 613 | 1,019 | 0.8% | 0.8% |
| Accelex Technology Limited | 534 | 788 | 0.5% | 953 | 1,406 | 1.0% | 0.8% |
| OpenDialog AI Limited | 1,162 | 1,162 | 0.8% | 1,011 | 1,011 | 0.7% | 0.8% |
| Imandra Inc. | 1,014 | 1,202 | 0.8% | 632 | 744 | 0.6% | 0.7% |
| Threadneedle Software Holdings Limited (T/A Solidatus) |
1,014 | 1,014 | 0.7% | 917 | 917 | 0.7% | 0.7% |
| Locum's Nest Limited | 813 | 1,240 | 0.8% | 452 | 689 | 0.5% | 0.7% |
| CRWN | AAVC | Enlarged Acquirer VCT |
|||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Quantexa Limited | 1,776 | 19,699 | 19.7% | – | – | – | 12.1% |
| Gravitee TopCo Limited (t/a Gravitee.io) |
1,724 | 2,783 | 2.8% | 2,189 | 3,560 | 5.7% | 3.9% |
| Chonais River Hydro Limited | 1,549 | 2,410 | 2.4% | 3,074 | 3,806 | 6.1% | 3.8% |
| Radnor House School (TopCo) Limited |
1,592 | 3,247 | 3.3% | 1,259 | 2,569 | 4.1% | 3.6% |
| Proveca Limited | 1,643 | 5,524 | 5.5% | – | – | – | 3.4% |
| The Evewell Group Limited | 1,240 | 2,625 | 2.6% | 1,272 | 2,644 | 4.2% | 3.2% |
| Runa Network Limited | 2,152 | 2,740 | 2.7% | 1,945 | 2,465 | 4.0% | 3.2% |
| Cantab Research Limited (T/A Speechmatics) |
1,521 | 1,723 | 1.7% | 2,234 | 2,530 | 4.1% | 2.6% |
| Healios Limited | 1,915 | 1,963 | 2.0% | 1,833 | 1,886 | 3.0% | 2.4% |
| Oviva AG | 1,766 | 3,821 | 3.8% | – | – | – | 2.4% |
| Elliptic Enterprises Limited | 1,255 | 1,263 | 1.3% | 2,155 | 2,169 | 3.5% | 2.1% |
| Gharagain River Hydro Limited | 1,116 | 1,574 | 1.6% | 1,363 | 1,716 | 2.8% | 2.0% |
| NuvoAir Holdings Inc. | 1,088 | 1,082 | 1.1% | 1,451 | 1,443 | 2.3% | 1.6% |
| Threadneedle Software Holdings Limited (T/A Solidatus) |
1,239 | 1,239 | 1.2% | 1,262 | 1,262 | 2.0% | 1.5% |
| TransFICC Limited | 1,066 | 1,238 | 1.2% | 1,025 | 1,259 | 2.0% | 1.5% |
| Accelex Technology Limited | 655 | 966 | 1.0% | 956 | 1,410 | 2.3% | 1.5% |
| CRWN | Enlarged Acquirer VCT |
||||||
|---|---|---|---|---|---|---|---|
| Company | Cost £'000 |
Valuation £'000 |
%GAV | Cost £'000 |
Valuation £'000 |
%GAV | %GAV |
| Peppy Health Limited | 1,157 | 1,157 | 1.2% | 1,207 | 1,207 | 1.9% | 1.5% |
| Seldon Technologies Limited | 1,193 | 742 | 0.7% | 2,539 | 1,580 | 2.5% | 1.4% |
The following table sets out further information on the largest three investments across the Albion VCTs:
| Company | Activity | Investment date |
Cost | Book value at 30 June 2024 |
Revenue growth from time of investment |
Employee growth from time of investment |
|---|---|---|---|---|---|---|
| Quantexa Limited | Uses big data analytics and artificial intelligence to help its banking, insurance and government customers detect financial crime |
2017 | £9.9m | £125.5m | >60x | 30 to 700+ |
| Proveca Limited | European speciality pharmaceutical company focused on children's medicines |
2012 | £12.6m | £44.0m | Invested pre-revenue. Now >£16m |
4 to 60+ |
| Oviva AG | A technology enabled service business in medical nutritional therapy (MNT) |
2016 | £11.1m | £24.1m | >30x | 20 to 500+ |
Current target sectors for new investments include:
| Albion Enterprise VCT % |
Albion Development VCT % |
Albion Technology & General VCT % |
Albion KAY VCT % |
Albion Crown VCT % |
Albion Venture Capital Trust % |
Total % |
|
|---|---|---|---|---|---|---|---|
| Healthcare (including digital healthcare) |
17 | 19 | 16 | 21 | 19 | 14 | 18 |
| FinTech | 25 | 26 | 31 | 23 | 31 | 18 | 26 |
| Other software & technology | 31 | 27 | 20 | 29 | 19 | 22 | 25 |
| Renewable energy | 4 | 5 | 6 | 8 | 6 | 14 | 7 |
| Other (including Education) | 3 | 4 | 7 | 1 | 5 | 11 | 4 |
| Cash | 20 | 19 | 20 | 18 | 20 | 21 | 20 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Albion Enterprise VCT % |
Albion Development VCT % |
Albion Technology & General VCT % |
Albion KAY VCT % |
Albion Crown VCT % |
Albion Venture Capital Trust % |
Total % |
|
|---|---|---|---|---|---|---|---|
| Under 20 | 4 | 5 | 6 | 6 | 6 | 10 | 6 |
| 21-50 | 14 | 14 | 16 | 15 | 18 | 27 | 16 |
| 51-100 | 13 | 15 | 12 | 23 | 15 | 14 | 15 |
| 101+ | 64 | 59 | 58 | 46 | 54 | 31 | 55 |
| Renewable energy* | 5 | 7 | 8 | 10 | 7 | 18 | 8 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
* Renewable energy investments have no employees.
| Albion Enterprise VCT % |
Albion Development VCT % |
Albion Technology & General VCT % |
Albion KAY VCT % |
Albion Crown VCT % |
Albion Venture Capital Trust % |
Total % |
|
|---|---|---|---|---|---|---|---|
| Early stage (revenue <£1m) | 6 | 6 | 7 | 9 | 7 | 12 | 8 |
| Growth (revenue between £1m and £5m) |
11 | 14 | 16 | 17 | 17 | 32 | 16 |
| Scale up (revenue >£5m) | 83 | 80 | 77 | 74 | 76 | 56 | 76 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
The following table sets out information on selected exits:
| Company | Amount invested |
Holding period |
Year of sale |
Acquirer | Total return to Albion VCTs (unaudited) |
|---|---|---|---|---|---|
| Ophelos | £3.2m | 1.4 years | 2023 | Intrum | 2.1x |
| Quantexa (partial disposal) | £0.9m | 6.6 years | 2023 | Albion Growth Opportunities Funds |
10.9x |
| Egress Software Technologies | £8.4m | 13.4 years | 2024 | KnowBe4 | 7.2x |
Under this power the Directors may impose any limits or restrictions and make any arrangements which they deem necessary or expedient to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or laws of, any territory or other matter, arising under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory or any other matter.
This power shall expire 15 months from the date that this resolution is passed, or, if earlier, the conclusion of the next Annual General Meeting of the Company, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if this power had not expired.
this authority offers or agreements which would or might require Albion Enterprise VCT Shares to be allotted or Rights to be granted after such expiry and the Albion Enterprise VCT Directors shall be entitled to allot Albion Enterprise VCT Shares or grant Rights pursuant to any such offers or agreements as if the authority conferred by this resolution had not expired; and
| Director | Albion Enterprise VCT No. of Shares |
% of issued Albion Enterprise VCT voting Share capital |
|---|---|---|
| Christopher Burrows | 259,936* | 0.23% |
| Rhodri Whitlock | 33,792 | 0.03% |
| Philippa Latham | 38,547** | 0.03% |
| Patrick Reeve | 97,639*** | 0.09% |
* Christopher Burrows (including his connected persons) also holds 108,147 Albion Development VCT shares which are expected to be converted into Albion Enterprise VCT shares pursuant to the AAEV/AADV Merger.
** Philippa Latham also holds 3,859 Albion Development VCT shares which are expected to be converted into Albion Enterprise VCT shares pursuant to the AAEV/AADV Merger.
*** Patrick Reeve also holds 178,887 Albion Development VCT shares which are expected to be converted into Albion Enterprise VCT shares pursuant to the AAEV/AADV Merger.
| Proposed Director | Albion Enterprise VCT No. of Shares |
% of issued Albion Enterprise VCT voting Share capital |
|---|---|---|
| Ben Larkin | 61,293* | 0.05% |
| Lord O'Shaughnessy | –** | – |
* Ben Larkin holds 628,180 Albion Development VCT shares which are expected to be converted into Albion Enterprise VCT shares pursuant to the AAEV/AADV Merger.
** Lord O'Shaughnessy holds 38,818 Albion Development VCT shares which are expected to be converted into Albion Enterprise VCT shares pursuant to the AAEV/AADV Merger.
In addition to the above, as at 11 November 2024, Albion Capital, of which Patrick Reeve is Chairman, holds 22,168 Albion Enterprise VCT Shares and 56,360 Albion Development VCT Shares.
It is estimated that the aggregate amount payable to the Albion Enterprise VCT Directors by Albion Enterprise VCT for the financial period ending on 31 March 2025 under the arrangements in force at the date of this document will not exceed £115,000 (plus payments in relation to out-of-pocket expenses). For the financial year ended 31 March 2024, former chairman Maxwell Packe received £31,000, Rhodri Whitlock received £29,000, Christopher Burrows received £26,000 and Philippa Latham received £26,000. The Albion Enterprise VCT Directors receive no other remuneration benefits in addition to their fees detailed above.
Assuming the Merger is implemented, Ben Larkin and Lord O'Shaughnessy will be appointed as directors of Albion Enterprise VCT. Their appointments will be pursuant to an appointment letter on similar terms as the current Albion Enterprise VCT Directors with an annual remuneration of £31,000 for Ben Larkin and £26,000 for Lord O'Shaughnessy.
(j) There have been no official public incriminations of and/or sanctions on any Albion Enterprise VCT Director by statutory or regulatory authorities (including designated professional bodies) and no Albion Enterprise VCT Director has ever been disqualified by a court from acting as a member of the administrative, management or supervisory bodies of a company or from acting in the management or conduct of the affairs of any company during the previous five years.
Under the Management Agreement, the Manager is paid an annual management fee equal to 2 per cent. of Albion Enterprise VCT's net assets which is paid quarterly in arrears. In addition, the Manager is paid an administration fee of 0.2 per cent. of Albion Enterprise VCT's net assets.
The total annual running costs of the Company, including fees payable to the Manager, Directors' fees, professional fees and the costs incurred by the Company in the ordinary course of business (but excluding any exceptional items and performance fees payable by the Manager) are capped at an amount equal to 2.5 per cent. of the Company's net assets, with any excess being met by the Manager by way of a reduction in management fees.
The Manager is, in addition, entitled to a performance fee. No performance fee is payable to the Manager until the total return exceeds the higher of (i) RPI plus 2 per cent per annum per Share and (ii) base rate plus 2 per cent. per annum per Share. If the target return is not achieved in a period, the cumulative shortfall is carried forward to the next accounting period and has to be made up before an incentive fee becomes payable. To the extent that the total return exceeds the threshold over the relevant period, a performance fee will be paid to the Manager of an amount equal to 20 per cent. of the excess.
The Management Agreement is terminable by either party by one year's prior written notice, subject to earlier termination by either party in the event of, inter alia, either party committing a material breach of the Management Agreement and failing to rectify the same within 45 days of being requested to do so or if Albion Enterprise VCT fails to become or ceases to be a venture capital trust for tax purposes or if the Manager shall cease to be lawfully able to carry out its obligations under the Management Agreement.
If terminated by Albion Enterprise VCT without due cause or on less than requisite notice, the Manager shall be entitled to receive an amount representing the fees which would have been payable during the period for which notice shall not have been given, calculated by reference to the previous quarterly payments.
The Management Agreement will terminate automatically without compensation, if either party enters into liquidation or has a receiver or administrator appointed over it or its assets, if the Manager ceases to be permitted to act as manager, if the Manager commits an act of fraud or upon the passing of a resolution for the voluntary liquidation, reconstruction or reorganisation of Albion Enterprise VCT as provided under Albion Enterprise VCT's Articles.
The Management Agreement contains provisions indemnifying the Manager against any liability not due to its default, negligence, fraud, breach of FSMA or the rules of the FCA.
In line with common practice in the VCT sector, the Manager is entitled to an arrangement fee, payable by each Investee Company, of approximately 2 per cent. on each investment made and is entitled to any non-executive director fees in respect of the Manager's representation on the boards of Investee Companies.
For the purposes of calculating the fees paid to the Manager, the values of the investments are calculated in accordance with Albion Enterprise VCT's normal accounting policies, with any disputes being referred to Albion Enterprise VCT's auditors.
The annual management fees will be charged as to 90 per cent. against capital reserves for accounting purposes, with the balance and all other expenses (other than expenses which are incidental to the purchase or disposal of an investment) being charged against revenue. 100 per cent. of any performance fees payable to the Manager and expenses which are incidental to the purchase or disposal of an investment will be charged against capital reserves.
The current dividend target of Albion Enterprise VCT per Albion Enterprise VCT Share is to pay 2.5 per cent. of the most recently announced net asset value per share when the dividend is announced twice a year, thereby targeting an annual dividend yield of around 5 per cent., but this cannot be guaranteed.
Under this power the Directors may impose any limits or restrictions and make any arrangements which they deem necessary or expedient to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or laws of, any territory or other matter, arising under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory or any other matter.
This power shall expire 15 months from the date that this resolution is passed, or, if earlier, the conclusion of the next Annual General Meeting of the Company, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if this power had not expired.
the annual general meeting of the Company to be held in 2025, but so that this authority shall allow the Company to make before the expiry of this authority offers or agreements which would or might require Albion Technology & General VCT Shares to be allotted or Rights to be granted after such expiry and the Albion Technology & General VCT Directors shall be entitled to allot such shares or grant Rights pursuant to any such offers or agreements as if the authority conferred by this resolution had not expired; and
| Director | Albion Technology & General VCT No. of Shares |
% of issued Albion Technology & General VCT voting Share capital |
|---|---|---|
| Clive Richardson | 12,500 | 0.01% |
| Margaret Payn | 13,985 | 0.01% |
| David Benda | 67,051 | 0.04% |
| Peter Moorhouse | 20,622* | 0.01% |
| Patrick Reeve | 626,691** | 0.33% |
* Peter Moorhouse holds 28,324 Albion KAY VCT Shares which are expected to be converted into Albion Technology & General VCT Shares pursuant to the AATG/KAY Merger.
** Patrick Reeve holds 259,292 Albion KAY VCT Shares which are expected to be converted into Albion Technology & General VCT Shares pursuant to the AATG/KAY Merger.
| Proposed Director | Albion Technology & General VCT No. of Shares |
% of issued Albion Technology & General VCT voting Share capital |
|---|---|---|
| Fiona Wollocombe | –* | –% |
| Swarupa Pathakji | –** | –% |
| Simon Thorpe | –*** | –% |
* Fiona Wollocombe holds 319,526 Albion KAY VCT Shares which are expected to be converted into Albion Technology & General VCT Shares pursuant to the AATG/KAY Merger.
** Swarupa Pathakji holds 50,974 Albion KAY VCT Shares which are expected to be converted into Albion Technology & General VCT Shares pursuant to the AATG/KAY Merger.
*** Simon Thorpe holds 93,327 Albion KAY VCT Shares which are expected to be converted into Albion Technology & General VCT Shares pursuant to the AATG/KAY Merger.
In addition to the above, as at 11 November 2024, Albion Capital, of which Patrick Reeve is Chairman, holds 38,198 Albion Technology & General VCT Shares and 139,974 Albion KAY VCT Shares.
It is estimated that the aggregate amount payable to the Albion Technology & General VCT Directors by Albion Technology & General VCT for the financial period ending on 31 December 2024 under the arrangements in force at the date of this document will not exceed £120,000 (plus payments in relation to out-of-pocket expenses). For the financial year ended 31 December 2023, Clive Richardson received £31,545, Margaret Payn received £31,000, David Benda received £14,019, Peter Moorhouse received £9,000, former chairman Robin Archibald received £15,122 and former director Mary Anne Cordeiro received £10,454. The Albion Technology & General VCT Directors receive no other benefits in addition to their fees detailed above.
Assuming the Merger is implemented, Fiona Wollocombe, Swarupa Pathakji and Simon Thorpe will be appointed as directors of Albion Technology & General VCT. Their appointments will be pursuant to an appointment letter on similar terms as the current Technology & General VCT Directors with an annual remuneration of £27,000 for Fiona Wollocombe, £27,000 for Swarupa Pathakji and £31,000 for Simon Thorpe.
Under the Management Agreement, the Manager is paid an annual fee equal to 2.0 per cent. of Albion Technology & General VCT's net assets which is paid quarterly in arrears. In addition, the Manager is paid an administration fee of 0.2 per cent. of Albion Technology & General VCT's net assets, subject to a maximum fee of £200,000 per annum and a minimum fee of £50,000 per annum, with a Board review every three years to consider inflation.
The total annual running costs of the Company, including fees payable to the Manager, Directors' fees, professional fees and the costs incurred by the Company in the ordinary course of business (but excluding any exceptional items and performance fees payable by the Manager) are capped at an amount equal to 2.75 per cent. of the Company's net assets, with any excess being met by the Manager by way of a reduction in management fees.
The Manager is, in addition, entitled to a performance fee. No performance fee is payable to the Manager until the total return exceeds 5 per cent. per annum per Share over a rolling five year period. To the extent that the total return exceeds the threshold over the relevant five year period, a performance fee will be paid to the Manager of an amount equal to 15 per cent. of the excess, measured on the weighted average number of shares in issue during the five year period.
The Management Agreement is terminable by either party by one year's prior written notice, subject to earlier termination by either party in the event of, inter alia, either party committing a material breach of the Management Agreement and failing to rectify the same within 45 days of being requested to do so or if Albion Technology & General VCT fails to become or ceases to be a venture capital trust for tax purposes or if the Manager shall cease to be lawfully able to carry out its obligations under the Management Agreement.
If terminated by Albion Technology & General VCT without due cause or on less than requisite notice, the Manager shall be entitled to receive an amount representing the fees which would have been payable during the period for which notice shall not have been given, calculated by reference to the previous quarterly payments.
The Management Agreement will terminate automatically without compensation, if either party enters into liquidation or has a receiver or administrator appointed over it or its assets, if the Manager ceases to be permitted to act as manager, if the Manager commits an act of fraud or upon the passing of a resolution for the voluntary liquidation, reconstruction or reorganisation of Albion Technology & General VCT as provided under Albion Technology & General VCT's Articles.
The Management Agreement contains provisions indemnifying the Manager against any liability not due to its default, negligence, fraud, breach of FSMA or the rules of the FCA.
In line with common practice in the VCT sector, the Manager is entitled to an arrangement fee, payable by each Investee Company, of approximately 2 per cent. on each investment made and is entitled to any non-executive director fees in respect of the Manager's representation on the boards of Investee Companies.
For the purposes of calculating the fees paid to the Manager, the values of the investments are calculated in accordance with Albion Technology & General VCT's normal accounting policies, with any disputes being referred to Albion Technology & General VCT's auditors.
The annual management fees will be charged as to 90 per cent. against capital reserves for accounting purposes, with the balance and all other expenses (other than expenses which are incidental to the purchase or disposal of an investment) being charged against revenue. 100 per cent. of any performance fees payable to the Manager and expenses which are incidental to the purchase or disposal of an investment will be charged against capital reserves.
Assuming (i) the Offer is fully subscribed and (ii) a fee of 3 per cent. of the gross proceeds of the relevant Offer applies to all subscriptions, under the November 2024 Offer Agreement the Manager will be entitled to, in the case of Albion Technology & General VCT, a commission of £900,000, which represents 0.6 per cent. of the net assets of Albion Technology & General VCT as at 30 June 2024 (being the latest date up to which Albion Technology & General VCT has published interim unaudited financial information).
The current dividend target of Albion Technology & General VCT per Albion Technology & General VCT Share is to pay 2.5 per cent. of the most recently announced net asset value per share when the dividend is announced twice a year, thereby targeting an annual dividend yield of around 5 per cent., but this cannot be guaranteed.
Under this power the Directors may impose any limits or restrictions and make any arrangements which they deem necessary or expedient to deal with any treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or laws of, any territory or other matter, arising under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory or any other matter.
This power shall expire 15 months from the date that this resolution is passed or, if earlier, the conclusion of the next Annual General Meeting of the Company, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if this power had not expired.
| Director | Albion Crown VCT No. of Shares |
% of issued Albion Crown VCT voting Share capital |
|---|---|---|
| James Agnew | 92,843 | 0.03% |
| Pam Garside | 108,617 | 0.04% |
| Ian Spence | 39,171 | 0.01% |
| Tony Ellingham | 31,948 | 0.01% |
| Proposed Director | Albion Crown VCT No. of Shares |
% of issued Albion Crown VCT voting Share capital |
|---|---|---|
| Richard Glover | –* | – |
| Ann Berresford | –** | – |
| Richard Wilson | 224,502*** | 0.07% |
* Richard Glover holds 88,681 Albion Venture Capital Trust Shares which are expected to be converted to Albion Crown VCT C Shares pursuant to the CRWN/AAVC Merger.
It is estimated that the aggregate amount payable to the Albion Crown VCT Directors by Crown Place VCT for the financial period ending on 30 June 2025 under the arrangements in force at the date of this document will not exceed £115,000 (plus payments in relation to out-of-pocket expenses). For the financial year ended 30 June 2024, James Agnew received £30,200, Pam Garside and Ian Spence each received £26,000, Tony Ellingham received £23,500 and former chairman Penny Freer received £12,200. The Albion Crown VCT Directors receive no other remuneration benefits in addition to their fees detailed above.
Assuming the Merger is implemented, Richard Glover, Ann Berresford and Richard Wilson will be appointed as directors of Albion Crown VCT. Their appointments will be pursuant to an appointment letter on similar terms as the Albion Crown VCT Directors with an annual remuneration of £31,000 for Richard Glover, £29,000 for Ann Berresford and £26,000 for Richard Wilson.
Under the Management Agreement, the Manager is paid an annual fee equal to 2.0 per cent. of Albion Crown VCT's net assets which is paid quarterly in arrears. In addition, the Manager is paid an administration fee of 0.2 per cent. of Albion Crown VCT's net assets, subject to a maximum fee of £200,000 per annum and a minimum fee of £50,000 per annum.
The total annual running costs of the Company, including fees payable to the Manager, Directors' fees, professional fees and the costs incurred by the Company in the ordinary course of business (but excluding any exceptional items and performance fees payable by the Manager) are capped at an amount equal to 3.0 per cent. of the Company's net assets, with any excess being met by the manager by way of a reduction in management fees.
In order to provide the Manager with an incentive to maximise the return to investors, the Manager is entitled to charge an incentive fee in the event that the returns exceed minimum target levels per Albion Crown VCT Share. The target level requires that the aggregate of the growth in the net asset value per Albion Crown VCT Share and dividends paid by Albion Crown VCT or declared by the Board and approved by the shareholders during the relevant period (both revenue and capital), compared with the previous accounting date, exceeds the average base rate of the Royal Bank of Scotland plc plus 2.0 per cent. If the target return is not achieved in a period, the cumulative shortfall is carried forward to the next accounting period and has to be made up before an incentive fee becomes payable. To the extent that the total return exceeds the threshold over the relevant period, a performance fee will be paid to the Manager of an amount equal to 20 per cent. of the excess.
The Management Agreement is terminable by either party by one year's prior written notice, subject to earlier termination by either party in the event of, inter alia, either party committing a material breach of the Management Agreement and failing to rectify the same within 45 days of being requested to do so or if Albion Crown VCT fails to become or ceases to be a venture capital trust for tax purposes or if the Manager shall cease to be lawfully able to carry out its obligations under the Management Agreement.
If terminated by Albion Crown VCT without due cause or on less than requisite notice, the Manager shall be entitled to receive an amount representing the fees which would have been payable during the period for which notice shall not have been given, calculated by reference to the previous quarterly payments.
The Management Agreement will terminate automatically without compensation, if either party enters into liquidation or has a receiver or administrator appointed over it or its assets, if the Manager ceases to be permitted to act as manager, if the Manager commits an act of fraud or upon the passing of a resolution for the voluntary liquidation, reconstruction or reorganisation of Albion Crown VCT as provided under Albion Crown VCT's Articles.
The Management Agreement contains provisions indemnifying the Manager against any liability not due to its default, negligence, fraud, breach of FSMA or the rules of the FCA.
In line with common practice in the VCT sector, the Manager is entitled to an arrangement fee, payable by each Investee Company, of approximately 2 per cent. on each investment made and is entitled to any non-executive director fees in respect of the Manager's representation on the boards of Investee Companies.
For the purposes of calculating the fee paid to the Manager, the values of the investments are calculated in accordance with Albion Crown VCT's normal accounting policies, with any disputes being referred to Albion Crown VCT's auditors.
The annual management fees will be charged as to 90 per cent. against capital reserves for accounting purposes, with the balance and all other expenses (other than expenses which are incidental to the purchase or disposal of an investment) being charged against revenue. 100 per cent. of any performance fees payable to the Manager and expenses which are incidental to the purchase or disposal of an investment will be charged against capital reserves.
Assuming (i) the Offer is fully subscribed and (ii) a fee of 3 per cent. of the gross proceeds of the relevant Offer applies to all subscriptions, under the November 2024 Offer Agreement the Manager will be entitled to, in the case of Albion Crown VCT, a commission of £900,000, which represents 0.9 per cent. of the net assets of Albion Crown VCT as at 30 June 2024 (being the latest date up to which Albion Crown VCT has published audited financial information).
The current dividend target of Albion Crown VCT per Albion Crown VCT Share is to pay 2.5 per cent. of the most recently announced net asset value per share when the dividend is announced twice a year, thereby targeting an annual dividend yield of around 5 per cent., but this cannot be guaranteed.
The principal object and purpose of each Company is to carry on business as a general commercial company.
The material provisions of the current Articles of each Company are as detailed below. The provisions set out below apply, mutatis mutandis, to each Company, unless otherwise stated. Reference in this section to the "Company" means, as the case may be, one or more Companies, references to the "Directors" and the "Board" mean the directors of or the board of directors of the relevant Company from time to time and references to the "Articles" are to the articles of association of the relevant Company.
(a) Subject to such of the restrictions of the Articles and CA 2006 as may be applicable, any member may transfer all or any of his shares by an instrument of transfer in the usual form or in any other form that the Board may approve. Such instrument shall be signed for or on behalf of the transferor and (in the case of a partly paid share) the transferee.
Where the Company's share capital is divided into different classes of shares, the rights attached to any shares or class of shares may be varied or abrogated in such manner (if any) as may be provided by such rights or, in the absence of any such provision, either with the written consent of the holders of not less than three-quarters in nominal value of the issued shares of that class (excluding any shares of that class held as treasury shares), or with the sanction of an extraordinary resolution passed at a separate general meeting of the holders of shares of that class of shares. The quorum for such a class meeting is two persons holding or representing by proxy at least one third of the nominal amount of the issued shares of that class.
The Company may from time to time in general meeting, by ordinary resolution, increase its share capital by such sums to be divided into shares of such amount as the resolution prescribes, consolidate and divide all or any of its share capital into shares of larger nominal amounts than its existing shares, cancel any shares which at the date of the passing of the resolution have not been taken or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled, and sub-divide its shares, or any of them into shares of a smaller amount and may by such resolution determine that, as between the shares resulting from such sub-division, one or more of the shares may, as compared with the others, have any such preferred or deferred or other special rights or be subject to any such restrictions as the Company has power to attach to unissued or new shares.
The Company may, subject to the provisions of CA 2006 and the Articles, by ordinary resolution from time to time declare dividends to be paid to members not exceeding the amount recommended by the Board. Subject to the provisions of CA 2006, in so far as, in the Board's opinion, the financial position of the Company justifies such payments, the Board may pay interim dividends on any class of shares including those carrying a fixed dividend. The Board may, if authorised by an ordinary resolution of the Company, offer shareholders in respect of any dividend the right to receive Shares instead of cash. The Board may withhold dividends payable (with no obligation to pay interest thereon) on shares (where such shares represent at least 0.25 per cent. of their class) after there has been a failure to provide the Company with information concerning interests in those shares required to be provided under the Articles or CA 2006 until such failure has been remedied. Any dividend unclaimed after a period of 12 years from the date such dividend is payable shall, if the Board resolves, be forfeited and shall revert to the Company.
At any time when the Company has given notice in the prescribed form (which has not been revoked) to the Registrar of Companies of its intention to carry on business as an investment company (a Relevant Period), distribution of the Company's capital profits (within the meaning of section 833(2)(c) of CA 2006) shall be prohibited except to the extent that the requirements for investment company status under section 833 of CA 2006 do not require a company to prohibit the distribution of its capital profits in its memorandum or articles of association. The Board shall establish a reserve to be called the capital reserve. During a Relevant Period, all surpluses arising from the realisation or revaluation of investments and all other monies realised on or derived from the realisation, repayment of or other dealing with any capital asset in excess of the book value thereof and all other monies which are considered by the Board to be in the nature of accretion to capital shall be credited to the capital reserve. Subject to CA 2006, the Board may determine whether any amount received by the Company is to be dealt with as income or capital or partly one way and partly the other. During a Relevant Period, any loss realised on the realisation or repayment of or other dealing with any investments or other capital assets and, subject to CA 2006, any expense or liability (or provision thereof) which the Board considers to relate to a capital item or which the Board otherwise considers appropriate to be debited to the capital reserve shall be carried to the debit of the capital reserve. During a Relevant Period, all sums carried and standing to the credit of the capital reserve may be applied for any of the purposes to which the sums standing to any revenue reserve are applicable except and provided that, notwithstanding any other provision of the Articles, no part of the capital reserve or any other money in the nature of accretion to capital shall be transferred to the revenue reserves of the Company or be regarded or treated as profits of the Company available for distribution (as defined by section 829 of CA 2006), except to the extent that the requirements for investment company status under section 833 of CA 2006 do not require a company to prohibit the distribution of its capital profits in its memorandum or articles of association, or be applied in paying dividends on any shares in the Company. In periods other than a Relevant Period, any amount standing to the credit of the capital reserve may be transferred to the revenue reserves of the Company or be regarded or treated as profits of the Company available for distribution (as defined by section 829 of CA 2006) or applied in paying dividends on any shares in the Company.
(a) Unless otherwise determined by ordinary resolution of the Company, the Directors (disregarding alternate Directors) shall not be less than two but there shall be no maximum number of Directors.
The Company may by ordinary resolution appoint a person who is willing to be a Director. The Board may appoint any person who is willing to act as a Director. The Board may appoint one or more of its body to hold any employment or executive office and may revoke or terminate such appointment, without prejudice to any claim for damages for breach of contract between the Director and the Company.
A Director shall not be required to hold any shares in the Company.
The Company may by ordinary resolution remove any director before the expiration of his period of office.
Any such authorisation may be given subject to terms and conditions as the Board think fit to impose at the time of such authorisation or subsequently and the authorisation may be varied or terminated by the Board at any time. Any such authorisation is only effective if given by the non-Conflicted Directors and if any requirement as to the quorum of the meeting is met by the non-Conflicted Directors.
If a matter has been so authorised by the Board, the Conflicted Director:
(and whether as an officer or shareholder, creditor or otherwise), does not hold or have a beneficial interest in one per cent. or more of either a relevant company or an intermediate company (as defined in the Articles) (any such interest being deemed for the purposes of this Article to be a material interest in all circumstances);
The Board may exercise all powers of the Company to borrow money and to mortgage or charge all or any part of its undertaking, property and assets (present and future) and uncalled capital and, subject to the provisions of CA 2006, to create and issue debentures, other loan stock and other securities, whether outright or as collateral security for any debt, liability or obligation of the Company or of any third party. Such powers are however limited so that the aggregate principal amount outstanding in respect of monies borrowed by the Company shall not, without the previous sanction of an ordinary resolution of the Company, exceed an amount equal to the adjusted share capital and reserves of the Company (for Albion Crown VCT), or 10 per cent. thereof (for Albion Enterprise VCT and Albion Technology & General VCT).
Subject to various notice requirements, the Company may sell at the best price reasonably obtainable any share held by a member provided that for a period of 12 years at least three dividends (whether interim or final) on those shares have become payable and no such dividend has been claimed, no cheque or warrant has been cashed and the Company has not received any communication during the relevant period from the holder of the shares.
Annual general meetings and other general meetings of the Company shall be called by at least such minimum period of notice as is prescribed under CA 2006.
Obligations by Shareholders to disclose to the Companies notifiable interests in their shares are stated in Part 22 of CA 2006, sections 89A to 89L of FSMA and the Disclosure and Transparency Rules. In accordance with the Articles, failure by any member to provide the Company with the information as requested by any notice serviced in accordance with section 793 of CA 2006 may result in the member being restricted in respect of his shareholdings and, inter alia, the withholding of any dividend payable to him.
Investments, including unquoted loan stocks, are designated as fair value through profit or loss ("FVTPL"). Unquoted investments' fair value is determined by the Directors in accordance with the International Private Equity and Venture Capital Valuation Guidelines (IPEV guidelines). The Directors' determination of fair value is guided by the quarterly valuations which are prepared by investment executives of the Manager and then reviewed by the Manager's valuation committee. Those valuations are then reviewed by the Directors, and, where they are to be included in the half-yearly and year end accounts, they are reviewed in detail at a meeting of the relevant Company's audit committee, with the auditor present at that meeting where it relates to valuations for the year end accounts. The auditor will also have conducted their own review of the valuations.
Any conflict of interest that the Manager may have in preparing the valuation of the Companies' assets is mitigated by the careful scrutiny of such valuations by the independent Directors of each Company, having particular regard to the potential for such conflicts between the interests of the Manager and the interests of their respective Company. All of this seeks to ensure that the valuation process is independent, contains adequate controls and mitigates any potential conflict of interests (that may arise insofar as the fees payable to the Manager for providing investment management or administrative services are determined by the NAV of the relevant Company, and insofar as any performance incentive fee payable by the relevant Company to the Manager pursuant to the Investment Management Agreement is also determined by the relevant Company's NAV).
Investments will usually be valued quarterly and the resulting net asset values will be communicated to Shareholders through a Regulatory Information Service. The Company will also announce when there has been a major change to its net asset value, for instance as a result of a disposal of an investment or if the Company undertakes a fundraising and needs to announce an interim valuation. The calculation of net asset value of the Company's investments will only be suspended in circumstances where the underlying data necessary to value the investments of the Company cannot readily, or without undue expenditure, be obtained. Details of any suspension would be announced through a Regulatory Information Service.
Ocorian Depositary (UK) Limited ("Ocorian") acts as custodian for each Company's unquoted assets and, in that capacity, is responsible for ensuring safe custody and dealing with settlement arrangements. Certificates representing the investments made by the Companies are segregated within a secure safe at the Companies' registered office. Ocorian is a limited company registered in England and Wales with registration number 08575830. Its registered office is at 5th Floor, 20 Fenchurch Street, London, EC3M 3BY. Ocorian is authorised and regulated by the FCA.
The following paragraphs, which are intended as a general guide only and are based on current legislation and HMRC practice, summarise advice received by the Directors as to the position of the Shareholders who hold shares other than for trading purposes. Any person who is in any doubt as to his taxation position or is subject to taxation in any jurisdiction other than the United Kingdom should consult their professional advisers.
Each Company has to satisfy a number of tests to continue to qualify as a VCT. A summary of these tests is set out below. The following information is based on current UK law and practice and is subject to changes therein, is given by way of a general summary and does not constitute legal or tax advice.
To qualify as a VCT, a company must be approved as such by HMRC. To obtain such approval it must:
The term "eligible shares" means shares which carry no preferential rights to assets on a winding-up and no rights to be redeemed, although they may have certain preferential rights to dividends.
A Qualifying Investment consists of shares or securities first issued to the VCT (and held by it ever since) by a company satisfying the conditions set out in Chapter 4 of Part 6 of ITA 2007.
The conditions are detailed, but include that the company must be a Qualifying Company, have gross assets not exceeding £15 million immediately before and £16 million immediately after the investment, have fewer than 250 full-time (or full-time equivalent) employees (fewer than 500 for a "knowledge intensive" company), apply the money raised for the purposes of a qualifying trade within a certain time period, cannot be controlled by another company and at the time of investment did not obtain more than £5 million (£10 million for a company deemed to be a "knowledge intensive" company) of investment from EU state aided risk capital measures in the twelve month period ending on the date of the investment by the VCT, and does not obtain a total of more than £12 million of such investment (£20 million for a company deemed to be a "knowledge intensive" company).
A Qualifying Company must be unquoted (for VCT purposes this includes companies whose shares are traded on AIM) and must meet a financial health requirement and carry on a qualifying trade. For this purpose certain activities are excluded such as dealing in land or shares or providing financial services. The qualifying trade must be less than seven years old (ten years for a "knowledge intensive" company) at the time of the first investment from State Aid Risk Finance (or a turnover test must be satisfied). The qualifying trade must either be carried on by, or be intended to be carried on by, the Qualifying Company or by a qualifying subsidiary at the time of the issue of shares or securities to the VCT (and at all times thereafter).
The company must have a permanent establishment in the UK, but the company need not be UK resident. A company intending to carry on a qualifying trade must begin to trade within two years of the issue of shares or securities to the VCT and continue it thereafter.
A Qualifying Company may have no subsidiaries other than qualifying subsidiaries which must, in most cases, be at least 51 per cent. owned.
There is a "disqualifying purpose" test under which an investment will not be a Qualifying Investment if the investee company has been set up for the purposes of accessing tax reliefs or is in substance a financing business. In addition, the investment must meet a "risk-to-capital" condition which requires that the investee company has long term growth plans, and that the investment is at risk.
VCT funds cannot be used by a Qualifying Company to fund the purchase of a business or of shares in another company.
A VCT must be approved at all times by HMRC. Approval has effect from the time specified at approval. A VCT cannot be approved unless the tests detailed above are met throughout the most recent complete accounting period of the VCT and HMRC is satisfied that they will be met in relation to the accounting period of the VCT which is current when the application is made. However, where a VCT raises further funds, VCTs are given grace periods to invest those funds before those funds need to meet such tests. Each Company has received approval as a VCT from HMRC.
Approval of a VCT may be withdrawn by HMRC if the various tests set out above are not satisfied. The exemption from corporation tax on capital gains will not apply to any gain realised after the point at which VCT status is lost. Withdrawal of approval generally has effect from time to time when notice is given to the VCT but in relation to capital gains tax of the VCT only can be backdated to not earlier than the first day of the accounting period commencing immediately after the last accounting period of the VCT in which all of the tests were satisfied.
Save as set out below, there are no material potential conflicts of interest which any of the service providers to each of the Companies may have as between their duty to that Company and the duties owed to third parties and their other interests.
The Manager may be involved in other financial, investment or professional activities that may on occasion give rise to conflicts of interest as between their duties to the Companies and duties owed by them to third parties and their other interests. In particular, it currently does, and may continue to, provide investment management, investment advice or other services in relation to a number of other funds or companies/clients that may have similar investment objectives and/or policies to that of the Companies and may receive ad valorem and/or performance-related fees for doing so. As a result, the Manager may have conflicts of interest in allocating investments among the Companies and other clients and in effecting transactions between the Company and other clients. The Manager may give advice or take action with respect to such other clients that differs from the advice given or actions taken with respect to the Companies.
The Boards of each of the Companies have noted that the Manager has other clients and have satisfied themselves that the Manager has procedures in place to address potential conflicts of interest. The procedures are designed to ensure that most conflicts are avoided (for example, restrictions on co-investment by staff, procedures relating to staff having outside appointments or other business interests, procedures relating to co-investments by other funds or limited partners and allocation across Albion Capital funds). The policy provides examples of potential conflicts and situations where one party could be favoured over another, to ensure that staff are suitably informed of likely potential conflicts that they must avoid or be alert to. The policy requires all staff to identify and disclose all potential conflicts of interest to the Managing Partner and Head of Compliance for them to assess the degree of risk and agree how the conflict must be managed. All conflicts are reported to the management board of Albion Capital. A conflicts register is maintained. In particular, prior to the launch of Albion Community Power PLC, the Companies were granted priority in respect of a certain level of renewable energy projects; and prior to the launch of Albion Care Communities Limited, the relevant Companies granted consent to Albion Care Communities Limited to undertake a certain number of new care home projects. Following changes in VCT legislation, the Companies are no longer permitted to invest in renewable energy projects or care home projects. Following shareholder approval, three of the Companies invested in the SVS Albion OLIM UK Equity Income Fund but these investments were subsequently sold. The level of the investment was subject to limits set out in the Companies' investment policies and the discretion of the Boards of the relevant Companies. The Companies may make a small number of deep tech co-investments with the UCL Technology funds.
The Valuations Policy section on page 74 identifies the potential conflicts of interest that the Manager may have in preparing the valuations of the Companies' assets and the steps the Companies, their Directors and the Manager undertake to mitigate such conflicts.
No person receiving a copy of this document in any territory other than the UK may treat the same as constituting an invitation or offer to him unless, in the relevant territory, such an invitation or offer could be lawfully made to him without contravention of any registration or other legal requirements.
The distribution of this document in jurisdictions other than the UK may be restricted by law and therefore persons into whose possession this document comes should inform themselves about and observe any of these restrictions. Any failure to comply with any of those restrictions may constitute a violation of the securities law of any such jurisdiction.
It is the responsibility of any person outside the UK wishing to make an application to satisfy himself as to the full observance of the laws of the relevant territory in connection therewith, including obtaining any requisite governmental or other consents, observing any other formalities required to be observed in such territory and paying any issue, transfer or other taxes required to be paid in such territory.
No action has been taken to permit the distribution of the Prospectus in any jurisdiction outside the UK where such action is required to be taken.
The New Shares have not been, nor will they be, registered in the United States under the United States Securities Act of 1933, as amended, (Securities Act) or under the securities laws of any Restricted Territory and they may not be offered or sold directly or indirectly within the United States or any of the Restricted Territories or to, or for the account or benefit of US Persons (as defined in Regulation S made under the Securities Act) or any national, citizen or resident of the United States or any of the Restricted Territories. The Offers are not being made, directly or indirectly, in or into the United States or any of the Restricted Territories or in any other jurisdiction where to do so would be unlawful. In particular, prospective shareholders who are resident in the United States or any Restricted Territory should note that this document is being sent for information purposes only.
All applicants under the Offers will be required to warrant that they are not a US Person (within the meaning of Regulation S made under the United States Securities Act of 1933, as amended), nor a resident, national or citizen of a Restricted Territory.
Where information has been sourced from a third party, this information has been accurately reproduced and as far as the Companies are aware and are able to ascertain from information published by that third party, no facts have been omitted which would render the reproduced information inaccurate or misleading.
Howard Kennedy Corporate Services LLP, which is authorised and regulated in the United Kingdom for the conduct of investment business by the FCA, is acting exclusively for the Companies and for no one else in connection with the Offers and, subject to the responsibilities and liabilities imposed by FSMA or the regulatory regime established thereunder, will not be responsible to any person other than the Companies for providing the protections afforded to customers of Howard Kennedy Corporate Services LLP or for providing advice to them in relation to the Offers or any other matter referred to in this document. Howard Kennedy Corporate Services LLP has given and not withdrawn its written consent to the inclusion in this document of references to its name in the form and context in which it appears.
Copies of the Articles of each of the Companies will be available for inspection during usual business hours on weekdays (weekends and public holidays excepted) at the registered offices of the Companies at 1 Benjamin Street, London EC1M 5QL, and may also be inspected at the following website: www.albion.capital/offers, whilst the Offers are open.
Dated: 12 November 2024
In this document, the following words and expressions have the following meanings:
| AAEV/AADV Merger | the proposed merger between AAEV and AADV pursuant to which shareholders in AADV are expected to receive Consideration Shares in AAEV |
|---|---|
| AAEV/AADV Scheme | the scheme of reconstruction regarding the AAEV/AADV Merger to be effected by means of placing AADV into members' voluntary liquidation pursuant to section 110 of IA 1986 and the acquisition by AAEV of all of AADV's assets and liabilities in consideration for the issue of Consideration Shares in AAEV on the basis set out in Part II of the Securities Note |
| AATG/KAY Merger | the proposed merger between AATG and KAY pursuant to which shareholders in KAY are expected to receive Consideration Shares in AATG |
| AATG/KAY Scheme | the scheme of reconstruction regarding the AATG/KAY Merger to be effected by means of placing KAY into members' voluntary liquidation pursuant to section 110 of IA 1986 and the acquisition by AATG of all of KAY's assets and liabilities in consideration for the issue of Consideration Shares in AATG on the basis set out in Part II of the Securities Note |
| Acquirer VCT | in the case of the AAEV/AADV Merger, Albion Enterprise VCT; in the case of the AATG/KAY Merger, Albion Technology & General VCT; in the case of the CRWN/AAVC Merger, Albion Crown VCT |
| Admission | the respective dates on which the New Shares allotted pursuant to the Offers and the Consideration Shares allotted pursuant to the Mergers are listed on the Official List and admitted to trading on the London Stock Exchange's main market for listed securities |
| AIC | the Association of Investment Companies |
| AIC Code | the AIC's Code of Corporate Governance issued in February 2019 |
| AIC Guide | the AIC Corporate Governance Guide for Investment Companies issued in February 2019 |
| AIM | the AIM Market of the London Stock Exchange |
| Albion Capital or the Manager | Albion Capital Group LLP (formerly Albion Ventures LLP) or its predecessor business |
| Albion Crown VCT or CRWN | Albion Crown VCT PLC |
| Albion Crown VCT Directors | the directors of Albion Crown VCT (and each an Albion Crown VCT Director) |
| Albion Crown VCT Offer | the offer for subscription of New Shares in Albion Crown VCT contained in the Prospectus |
| Albion Development VCT or AADV | Albion Development VCT PLC |
| Albion Enterprise VCT or AAEV | Albion Enterprise VCT PLC |
| Albion Enterprise VCT AAEV Directors |
the directors of AAEV (and each an Albion Enterprise VCT Director) |
| Albion Enterprise VCT Offer | the offer for subscription of Offer Shares in Albion Enterprise VCT contained in the Prospectus |
| Albion KAY VCT or KAY | Albion KAY VCT PLC |
| Albion Technology & General VCT or AATG |
Albion Technology & General VCT PLC |
| Albion Technology & General VCT Directors |
the directors of Albion Technology & General VCT (and each an Albion Technology & General VCT Director) |
| Albion Technology & General VCT Offer |
the offer for subscription of Offer Shares in Albion Technology & General VCT contained in the Prospectus |
| Albion VCTs | Albion Development VCT, Albion Enterprise VCT, Albion Technology & General VCT, Albion Venture Capital Trust, Albion Crown VCT and Albion KAY VCT (and each an Albion VCT) |
| Albion Venture Capital Trust or AAVC |
Albion Venture Capital Trust PLC |
|---|---|
| Articles | the articles of association of the relevant Company, as amended from time to time |
| Boards | the boards of Directors of the Companies (and each a Board) |
| Business Day | any day (other than a Saturday or Sunday) on which clearing banks are open for normal banking business in sterling |
| CA 2006 | the Companies Act 2006 (as amended) |
| Circular | the joint circular issued by the Albion VCTs dated 12 November 2024 in connection with the Mergers and the Offers |
| Consideration Shares | shares issued pursuant to the AAEV/AADV Merger, the AATG/KAY Merger and the CRWN/ AAVC Merger (and each a Consideration Share) |
| Companies | Albion Enterprise VCT, Albion Technology & General VCT and Albion Crown VCT (and each a Company) |
| CREST | the computerised settlement system to facilitate the transfer of title to securities in uncertificated form operated by Euroclear UK & Ireland Limited |
| CRWN Shares | ordinary shares of 1 penny each in the capital of CRWN |
| CRWN/AAVC Merger | the proposed merger between CRWN and AAVC pursuant to which shareholders in AAVC are expected to receive New CRWN Shares |
| CRWN/AAVC Scheme | the scheme of reconstruction regarding the CRWN/AAVC Merger to be effected by means of placing AAVC into members' voluntary liquidation pursuant to section 110 of IA 1986 and the acquisition by CRWN of all of AAVC's assets and liabilities in consideration for the issue of New CRWN on the basis set out in Part II of the Securities Note |
| Directors | the directors of the Companies (as the context permits)(and each a Director) |
| Disclosure Guidance and Transparency Rules |
the disclosure guidance and transparency rules made by the FCA under section 73A of FSMA |
| Enlarged Acquirer VCTs | AAEV, AATG and CRWN following the relevant Merger being implemented (and each an Enlarged Acquirer VCT) |
| FCA | the Financial Conduct Authority |
| FSMA | the Financial Services and Markets Act 2000 (as amended) |
| GAV | gross asset value |
| General Meetings | the general meetings of the Companies and the Target VCTs convened for 11 December 2024, and the further general meetings of the Target VCTs convened for 19 December 2024 (including, with respect to each of them, any adjournment thereof) |
| HMRC | His Majesty's Revenue and Customs |
| IA 1986 | the Insolvency Act 1986 (as amended) |
| ITA 2007 | the Income Tax Act 2007 (as amended) |
| Liquidators | Karen Spears and Gareth Harris of RSM UK Restructuring Advisory LLP of 6th Floor 25 Farringdon Street, London, EC4A 4AB |
| Listing Rules | the listing rules made by the FCA under section 74 of FSMA |
| LLP | a limited liability partnership |
| London Stock Exchange | London Stock Exchange plc |
| Mergers | the AAEV/AADV Merger, the AATG/KAY Merger and the CRWN/AAVC Merger (and each a Merger) |
|---|---|
| NAV or net asset value | in relation to a share, the net asset value of a share calculated in accordance with the relevant company's accounting policies and, in relation to a company, the aggregate net asset value attributable to that company's issued shares (excluding any shares held in treasury) |
| New CRWN Shares | new ordinary C shares of 1 penny each in the capital of CRWN to be issued to the AAVC Shareholders pursuant to the CRWN/AAVC Merger |
| Offer Price | the subscription price of the Offer Shares under each Offer as calculated in accordance with the Pricing Formula |
| Offer Shares | new Shares in a Company to be issued under its Offer |
| Offers | the Albion Enterprise VCT Offer, the Albion Technology & General VCT Offer and the Albion Crown VCT Offer (and each an Offer) |
| Official List | the Official List of the FCA |
| Pricing Formula | the formula to be used to calculate the Offer Price of the Offer Shares under each Offer as set out in the Securities Note |
| Proposed Directors | the proposed directors of each Company to be appointed on the implementation of the relevant Merger |
| Prospectus | this Registration Document, the Securities Note and the Summary |
| Qualifying Company | an unquoted (including AIM-traded) company which satisfies the requirements of Part 4 of Chapter 6 of ITA 2007 |
| Qualifying Investment | shares in, or securities of, a Qualifying Company held by a VCT which meet the requirements of Part 4 of Chapter 6 of ITA 2007 |
| Qualifying Investor | an individual aged 18 or over who satisfies the conditions of eligibility for tax relief available to investors in a VCT |
| Registrars | Computershare Investor Services PLC |
| Registration Document | this document |
| Regulatory Information Service | a regulatory information service approved by the FCA |
| Resolutions | the resolutions to be proposed at the General Meetings, as the context permits (and each a Resolution) |
| Restricted Territories | Canada, Australia, Japan and South Africa |
| Revised Articles | the articles of association of CRWN to be proposed for adoption at the Albion Crown VCT General Meeting (such articles of association containing provision for the New CRWN Share class their conversion into ordinary shares of 1 penny each in the capital of CRWN in accordance with the terms of those articles of association) |
| Schemes | the AAEV/AADV Scheme, the AATG/KAY Scheme and the CRWN/AAVC Scheme (and each a Scheme) |
| Securities Note | the securities note issued by the Companies dated 12 November 2024 in connection with the Mergers and the Offers |
| Shareholders | holders of Shares in any one or more of the Companies (and each a Shareholder) |
| Shares | ordinary shares of 1 penny each in the capital of a Company and/or (as the context requires) New CRWN Shares (and each a Share) |
| Sponsor | Howard Kennedy Corporate Services LLP |
| Summary | the summary issued by the Companies dated 12 November 2024 in connection with the Mergers and the Offers |
|---|---|
| Target VCT | in the case of the AAEV/AADV Merger, Albion Development VCT; in the case of the AATG/ KAY Merger, Albion KAY VCT; in the case of the CRWN/AAVC Merger, Albion Venture Capital Trust |
| UK Corporate Governance Code | the UK Corporate Governance Code issued by the Financial Reporting Council in July 2018 |
| UK Prospectus Regulation | the UK version of Regulation (EU) 2017/1129 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 |
| VCT Value | the value of an investment calculated in accordance with section 278 of ITA 2007 |
| Venture Capital Trust or VCT | a venture capital trust as defined in section 259 of ITA 2007 |
Christopher Burrows (Chairman)1 Philippa Latham2 Rhodri Whitlock3/5 Patrick Reeve
Clive Richardson (Chairman) 1/4 David Benda Peter Moorhouse2 Margaret Payn3/5 Patrick Reeve
James Agnew (Chairman)1 Tony Ellingham3 Pam Garside5 Ian Spence2
Albion Capital Group LLP 1 Benjamin Street London EC1M 5QL Telephone: 020 7601 1850
Howard Kennedy LLP No. 1 London Bridge London SE1 9BG
Ben Larkin (Chairman) Christopher Burrows1 Philippa Latham2 Lord O'Shaughnessy Rhodri Whitlock3/5
Clive Richardson (Chairman)1/4 David Benda2 Fiona Wollocombe Swarupa Pathakji Simon Thorpe3/5
Richard Glover (Chairman)1 Ann Berresford3 Pam Garside5 Ian Spence2 Richard Wilson
The relevant webpage on the Manager's website at: www.albion.capital
Howard Kennedy Corporate Services LLP No. 1 London Bridge London SE1 9BG
City Partnership (UK) Limited The Mending Rooms Park Valley Mills Meltham Road Huddersfield HD4 7BH Telephone: 01484 240910
Johnston Carmichael LLP 7-11 Melville Street Edinburgh EH3 7PE
Philip Hare & Associates LLP 6 Snow Hill London EC1A 2AY
Computershare Investor Services PLC The Pavilions Bridgwater Road Bristol BS99 6ZZ Telephone: 0370 702 0000
Karen Spears and Gareth Harris RSM UK Restructuring Advisory LLP 6th Floor, 25 Farringdon Street London EC4A 4AB
Panmure Liberum Limited Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY
Ocorian Depositary (UK) Limited Level 5, 20 Fenchurch Street London EC3M 3BY
Macintyre Hudson LLP Moorgate House 201 Silbury Boulevard Milton Keynes MK9 1LZ
Address 1 Benjamin Street, Farringdon, London, EC1M 5QL Telephone 020 7601 1850
Website www.albion.capital
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.